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EXECUTIVE SUMMARY 
A literature survey was conducted to assess if published data (evidence) could help 
inform a space suit carbon dioxide (CO2) limit. The search identified more than 120 documents 
about human interaction with elevated CO2. Until now, the guiding philosophy has been to drive 
space suit CO2 as low as reasonably achievable. NASA’s EVA Office requested an evidence-
based approach to support a new generation of exploration-class extravehicular activity (EVA) 
space suits. Specific literature data about CO2 are not available for EVA in microgravity because 
EVA is an operational activity and not a research platform. However, enough data from ground-
based research are available to facilitate a consensus of expert opinion on space suit CO2 limits. 
The compilation of data in this report can answer many but not all concerns about the 
consequences of hypercapnic exercise in a space suit. Inspired partial pressure of CO2 (PICO2) 
and not dry-gas partial pressure of CO2 (PCO2) is the appropriate metric for hypercapnic dose to 
establish space suit CO2 limits. The reduction of inspired gas partial pressures by saturation of 
the inspired gases with water vapor at 37°C is a significant factor under conditions of hypobaric 
space suit operation. Otherwise healthy EVA astronauts will exhibit wide variability in responses 
to acute hypercapnia while at rest and during exercise. What is clear from the literature is the 
absence of prospective (objective) accept or reject criteria for CO2 exposure in general, and no 
such criteria exist for operating a space suit. There is no absolute “Gold Standard” for an 
acceptable acute hypercapnic limit, just a gradual decrease in performance as CO2 increases. 
Acceptable CO2 exposure limits are occupation, situation (learned or novel tasks), and person-
specific. Investigators who measured hypercapnic physiology rarely correlated those changes to 
neurocognitive symptoms, and those that measured hypercapnic neurocognition rarely correlated 
those changes with physiology. Some answers about changes in neurocognition and functional 
EVA performance during hypercapnic exercise in a space suit await new research.
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1.0 INTRODUCTION  
Humans function properly with a steady-state store of carbon dioxide (CO2), mostly in 
the form of bicarbonate ions (HCO3-), and too much or too little CO2 is disruptive to 
homeostasis. The body exquisitely regulates tissue CO2 and oxygen (O2) tensions. CO2 
regulation maintains hydrogen ion concentration [H+, pH] compatible with efficient cell 
function. CO2 is a product of cellular metabolism of carbohydrates, fats, and proteins and must 
be removed from the tissues by the integrated cardiopulmonary system at a rate that matches 
CO2 production or the steady-state balance is disrupted. At rest, steady-state production of CO2 is 
about 250 mL(STPD)/min and at steady-state maximum exercise is about 4,000 mL(STPD)/min. CO2 
concentration is controlled locally at the tissue level by adjusting blood perfusion and broadly by 
chemoreceptors in the carotid bodies, arch of the aorta, and within the medulla oblongata with 
cardiopulmonary response integrated by the central nervous system (CNS). On average, 
combining rest with modest activity, the body effortlessly eliminates about 20 moles of CO2 (880 
g) per day of this volatile acid to preserve a normal alkaline pH of 7.40.  
Vascular reactivity, particularly cerebral blood flow (CBF), is sensitive to changes in 
arterial blood CO2 partial pressure (PaCO2) (Ainslie and Duffin 2009), (Sliwka, Krasney et al. 
1998), (Halpern, Neufeld et al. 2003). CO2 mediates its effect on CBF through alteration of [H+] 
of the cerebrospinal fluid (CSF). Over a wide range of PaCO2 from 20 to 80 mmHg, the CBF 
changes 1–2 mL/100 g brain/min for each 1 mmHg change in PaCO2. During sustained 
alterations of PaCO2, CBF returns to baseline over several hours due to a correction of brain 
extracellular pH (Brian 1998), (Sliwka, Krasney et al. 1998). Sliwka insonated the middle 
cerebral arteries of 4 males exposed to 23 days of 0.7% CO2 and another 23 days of 1.2% CO2. 
CBF was elevated by 35% during the first 1–3 days of both exposures but then returned to pre-
test levels. Despite similar CBF responses, headache was only reported during the initial phase of 
exposure to 1.2% CO2. Performance of muscles, even respiratory muscles like the diaphragm, is 
influenced by acute respiratory acidosis when PaCO2 exceeds 54 mmHg (Juan, Calverley et al. 
1984). The lung itself is a target organ for changes in respiratory CO2 and O2. Smooth muscle in 
terminal bronchioles and pulmonary arterioles contract under either hypercapnia or hypoxia and 
relax under hypocapnia or hyperoxia (Balanos, Talbot et al. 2003), (Sheehan and Farhi 1993). 
More on this later, but clearly CO2, O2, and even nitric oxide (NO) (Stamler, Jia et al. 1997), 
have critical roles in modulating the distribution of alveolar ventilation rate (V̇A) and blood 
perfusion rate (cardiac output, Q̇) in the lung and modulating perfusion rate through all vascular 
beds to preserve homeostasis.   
During rest and exercise, the inhalation of extraneous CO2 opposes the exhalation of 
metabolic CO2. Acidified venous blood needs to transport CO2 for removal and return as pH-
normal arterial blood. If this is hindered, then there are physiologic and therefore neurocognitive 
and performance consequences to hypercapnia. Heavy exercise during hypercapnia will place 
excessive demands upon ventilation that will limit exercise capacity. Retention of CO2 occurs 
when alveolar ventilation does not increase sufficiently to compensate for its reduced 
effectiveness in CO2 elimination.  
During extravehicular activity (EVA), astronauts will rebreathe CO2, particularly during 
periods of physical activity, because helmet CO2 washout is never perfect. In addition, any 
compromised suit ventilation and degradation of CO2 removal capacity will also increase 
inspired CO2 partial pressure (PICO2). Therefore, we will assess from a literature review the 
human physiologic, neurocognitive, and functional performance responses across a range of CO2 
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partial pressure (PCO2) from 0 to 20 mmHg and a range of O2 consumption from 250 mL(STPD) 
O2/min to 2,500 mL(STPD) O2/min (from 300 to 3000 BTU/h). These ranges of PCO2 and 
metabolic rates are possible during EVA and to a lesser degree during launch, entry, and abort 
(LEA) scenarios where astronauts are in a pressurized suit. Our analysis of the literature data 
may provide enough evidence to establish operational limits that assures safety and maintains 
health and performance during EVA and LEA with PCO2 >0 mmHg. Ultimately, a consensus of 
opinion after a review of evidence by medical, operational, and life science experts will establish 
limits. 
 As a point of departure from previous reviews, in 1993 Seter (Seter 1993) provided an 
extensive literature review titled, “Allowable Exposure Limits for Carbon Dioxide during 
Extravehicular Activity”. He recommended a PCO2 limit of 3.8 mmHg for nominal operations in 
a space suit with 7.6 mmHg for heavy exertion. This reduced by half the NASA limit of 7.6 
mmHg for nominal and 15.2 mmHg for heavy exertion, which was a consensus opinion 
extending back to 1969 (Michel, Sharma et al. 1969), (Roth 1968). Other reviews since 1969 
consistently recommended 7.6 mmHg as an upper limit for nominal EVA, and then added 
conditions (time limits or corrective actions) if PCO2 was >7.6 mmHg (Furr, Monson et al. 
1988), (Waligora 1979). Furr, in his 1988 review, says “The question addressed here is: During 
EVA, what level of carbon dioxide should be tolerated?” In 2018 we are still asking this 
question. Glatte (Glatte Jr and Welch 1967) provided an extensive review in 1967, extending 
back into the 1920s. His early review is mentioned here because he parsed data into acute and 
chronic exposure to CO2 and further stratified responses into 6 major groupings: a) lung [tidal 
volume (VT), minute volume rate (V̇E), alveolar CO2 partial pressure (PACO2)], b) arterial blood 
(pH and CO2 content), c) kidney, d) CNS, e) overt symptoms, and f) performance. He defined 
acute exposure as 4 hours, which is not unreasonable for an EVA, and covered a range of PCO2 
from 4 to 21 mmHg in his Table III. He identifies increased VT, V̇E, PACO2, and blood content of 
CO2, with decreased arterial pH, few symptoms of dyspnea, and no performance degradation at a 
PCO2 of about 15 mmHg, a conclusion worthy of note.  
 A literature review by Knafelc (Knafelc 2000) titled, “Physiological Basis for CO2 Limits 
within Semiclosed and Closed-Circuit Underwater Breathing Apparatus” concluded that 
underwater work and cognitive performance were not significantly affected at PCO2 <15.2 
mmHg. However, the prevailing Navy standard of 3.8 mmHg for these breathing devices was 
still recommended because divers also have the additional stressors of decompression sickness 
(DCS), nitrogen (N2) narcosis, O2 toxicity, and CO2 retention due to high-resistance breathing 
equipment (Henning, Sauter et al. 1990). All these stressors are exacerbated by hypercapnia. An 
EVA astronaut in a low-pressure space suit is exempt from N2 narcosis, O2 toxicity, and has no 
CO2 retention due to breathing resistance; however, he or she is at some risk for DCS. Finally, in 
1992 Wong (Wong 1992) of the Johnson Space Center (JSC) Toxicology Group provided an 
exhaustive review of CO2 exposure in humans and animals as part of a National Research 
Council Subcommittee review of Spacecraft Maximum Allowable Concentrations (SMAC) for 
airborne spacecraft contaminants. The goal was to set SMAC values for space habitation in 
general; however, literature about CO2 exposure was cited that has application to EVA. Dr. 
Wong provided a Toxicity Summary Table specific for human CO2 exposures that we include in 
the Appendix. Simply scanning down the table from the lowest (0.5% CO2) to highest (30% 
CO2) CO2 concentrations provides the reader with an impression of the physiologic, 
neurocognitive, and performance impacts of normobaric hypercapnia in 1G. It appears to this 
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reviewer that acute exposure to PCO2 <22.8 mmHg (3% CO2) during EVA would be 
operationally acceptable, assuming that µG and 1G exposures are otherwise equivalent. His 
numerous references are also provided and the  symbol indicates data from humans, as a 
resource.   
 It follows from above that a PCO2 limit for a diver, an office worker, an airline 
passenger, a coal miner, a fire fighter, a submersible operator and a different PCO2 limit for an 
aviator or astronaut would be justified, as the PCO2 limit is occupation-specific and situation-
specific. This is the challenge when evaluating current requirements by various regulatory 
agencies. Each requirement is correct within the context that it applies. There is no one “Gold 
Standard”. For example, the American Society of Heating, Refrigeration, and Air Conditioning 
Engineers, the American Conference of Governmental Industrial Hygienists, and the U.S. 
Occupational Safety and Health Administration all dictate standards for air quality in different 
work environments that usually incorporate a significant safety factor for CO2 exposure. NASA, 
the European Space Agency, and the Deutsche Agentur fur Raumfahrtangelegenheiten sponsored 
research to set limits for ambient CO2 levels for extended space habitation. This research 
produced 10 papers based on 4 subjects covering physiologic and mental performance, including 
sleep quality and exercise performance (Frey, Sulzman et al. 1998). The general conclusion was 
that no serious medical concerns emerged with PCO2 <9 mmHg (1.2%) for exposures lasting 
about 3 weeks, but this was based on research in 1G. 
2.0 SPECIFIC AIMS 
This effort is to evaluate compiled evidence (data) from a comprehensive literature 
review of changes in physiologic, neurocognitive, and performance in response to increased 
PCO2 with specific application to EVA and LEA events with astronauts in pressurized suits. 
Astronauts during EVA will breathe elevated levels of CO2, particularly during periods of 
physical activity, because helmet CO2 washout is never perfect and compromised suit ventilation 
and degradation of CO2 removal capacity will also increase PCO2. There is no single a priori 
acceptable limit for PCO2 exposure; any proposed limit is occupation-specific, situation-specific, 
and even person-specific. However, there is a philosophy that states breathing gas free of CO2 is 
preferred. As low as reasonably achievable (ALARA) with an upper acceptable limit for EVA 
seems a practical approach to move forward with human exploration of space. The model for 
EVA is similar to that for setting exposure limits for a toxicant in a work environment (8 h/day 
and 40 h/wk) given that the toxicant in the living environment is absent or present in a 
significantly lower concentration.   
3.0 MAJOR GOALS OF LITERATURE REVIEW 
1. Quantify interactions between ambient pressures (PB), PO2, PCO2, exercise, and gravity 
to provide specific space suit PCO2 limit(s) applicable to EVA and LEA. 
2. Define acceptable deviation(s) in physiology as a function of PCO2 and recommend 
space suit PCO2 limit(s) for EVA/LEA. 
3. Define acceptable deviation(s) in neurocognition as a function of PCO2 and recommend 
space suit PCO2 limit(s) for EVA/LEA. 
4. Define acceptable deviation(s) in functional performance as a function of PCO2 and 
recommend space suit PCO2 limit(s) for EVA/LEA. 
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5. Identify health effects from repeated, acute hypercapnic exposures and recommend space 
suit PCO2 limit(s) for repeated EVAs. 
 Does a focused review of the literature about acute exposure to CO2 combined with 
exercise provide adequate evidence (data) to establish operational limits for EVA and LEA under 
hypobaric conditions in <1G environments? If yes, then operational limits will be defined based 
on a Delphi-method review of literature evidence. If no, then does the absence of data from the 
literature suggest a clear research protocol to achieve the goal of establishing operational limits 
for EVA and LEA, given that the majority of testing is limited to 1G? A second related question 
is do these literature data eliminate the need to validate operational limits in a ground-based 
study before implementation?  
4.0 LITERATURE SEARCH SPECIFIC TO ACUTE EXTRAVEHICULAR 
ACTIVITY CONDITIONS 
To limit the scope of the literature review, we focus mainly on acute exposure to CO2 
combined with rest and exercise. There is a vast literature on chronic exposure to low-level CO2. 
For example, exposure to 1.5% CO2 for 42 days in active submariners induced respiratory 
acclimatization and CO2 retention but was well tolerated and reversible on reexposure to fresh air 
(Schaefer, Hastings et al. 1963). We would prefer to review only specific data about hypercapnia 
combined with exercise with physiologic, neurocognitive, and performance responses in a 
hypobaric, hyperoxic space suit in a µG environment. However, no comprehensive data set 
collected under these conditions currently exists in the literature even after 60 years of EVA 
experience with astronauts and cosmonauts. Also, no data exists about chronic exposure to low-
level PCO2 followed by acute exposure to higher-level PCO2, as one might expect during 
exploration EVA activity from a habitat. The operational philosophy has been to minimize, 
rather than accommodate hypercapnia. Therefore, recommendations for EVA and LEA will 
necessarily come from extrapolations of literature evidence and the assumption that all 
extrapolations are valid.  
 The responses to hypercapnia are modified by other gases like O2 and N2, depending on 
their partial pressures. But to stay focused, we do not cover to a great extent the interactions 
between CO2 and hyperbaric hyperoxia (O2 toxicity, (Lambertsen, Hall et al. 1963), (Bitterman 
and Bitterman 1998)) or CO2 and increased PN2 (N2 narcosis, (Fothergill, Hedges et al. 1991)), 
or CO2 and risk of DCS, or CO2 and hypoxia (Nielsen and Smith 1952), (Cormack, Cunningham 
et al. 1957), or CO2 and CO2 retention due to high breathing resistance (Warkander, Norfleet et 
al. 1990). Our focus is primarily on acute hypercapnia in normobaric normoxia at rest and 
exercise and in acute hypobaric normoxia at rest and exercise. Establishing chronic CO2 
exposure limits in spacecraft (Gemini, Apollo, Skylab, Space Shuttle, Neurolab, International 
Space Station (ISS)) is not our focus; however, this process has relevance to EVAs because they 
occur in µG. Waligora (Waligora 1992) briefly reviewed the history of spacecraft CO2 limits in 
1992 and offered a recommendation of ≤3 mmHg for the then Space Station Freedom.  
 Fresh air at sea level pressure (760 mmHg) has about 0.03% CO2 (300 ppm), a PCO2 of 
about 0.23 mmHg. A chronic exposure to 1% CO2 (7.6 mmHg at 760 mmHg, 10,000 ppm) does 
not significantly limit human health or performance on Earth (Frey, Sulzman et al. 1998). 
However, with sensitive instruments it is possible to show measurable changes in cognition and 
physiology even with respired PCO2 <7.6 mmHg (James 2007), (Satish, Mendell et al. 2012), 
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(Cronyn, Watkins et al. 2012), (Frey, Sulzman et al. 1998). The current NASA operational 
approach to limit chronic PCO2 exposure on the ISS is to maintain 24-hour levels to ≤3 mmHg. 
It is not possible with current space suit engineering to match this goal during EVA. A 
distinction is made between chronic and acute CO2 exposure, with the avoidance of acute 
symptoms as the primary consideration for limits in a space suit.  
 Limiting exposure time permits a greater PCO2. During EVA, currently no corrective 
action is required until the inlet PCO2 from the CO2 scrubber exceeds 3 mmHg; however, at 8 
mmHg or if symptoms are present, the helmet purge valve must be opened and at 12.4 mmHg, 
which corresponds to a PICO2 of 9.8 mmHg, the helmet purge valve must be opened even in the 
absence of symptoms. This action corrects for the higher but unknown PCO2 in the helmet that is 
causing symptoms or instances in which CO2 removal capability is near exhaustion, or both. In 
contrast, Mekjavic (Mekjavic IB 1992) references a 1990 requirement from the Norwegian 
Petroleum Directorate that submersibles and atmospheric diving suits not exceed 3.8 mmHg in a 
6-hour working dive, with allowance to 15.2 mmHg over the next 48 hours in the event the 
recovery is delayed.  
 In the case of the astronaut, it is uncertain what the actual helmet PCO2 is because the 
free volume (dead space) of the helmet depends on the volume of the head and communication 
equipment, the CO2 washout efficiency for a given helmet ventilation flow rate, the position of 
the head at any moment, and the minute-by-minute metabolic rate of the astronaut. A concerted 
effort is underway to standardize helmet CO2 washout measurement methodology (Bekdash, 
Norcross et al. 2017). Historically, Michel (Michel, Sharma et al. 1969) used PCO2 at the end of 
inhalation and found it increased 1–2  mmHg for rest, 3.5 mmHg at 1000 BTU/h, and about 7 
mmHg at 2000 BTU/h during suited (Apollo A-5L) treadmill exercise at 18.4 psia with helmet 
ventilation at about 6 actual cubic feet per minute (ACFM). He concedes this approach 
underestimated the actual PICO2 because it ignored rebreathing helmet CO2 during initial 
inhalation. However, it was adequate to evaluate a range of helmet ventilation rates combined 
over a range of exercise intensity. Wick (Wick 1966) evaluated different sampling methods in an 
unpressurized Gemini (G2C) suit where 0%, 1%, 2%, or 3% CO2 was delivered to the suit at 11 
cubic feet per minute (CFM) with subjects at rest on a chair or while walking at 3 mph on a 
treadmill. This was the first and only time that arterial blood for PaCO2 assesment was collected 
during suited exercise. Mean PaCO2 in 10 males increased to 57 mmHg during the brief exercise 
(mean 2,050 BTU/h) with inlet CO2 at 3%.  
 A goal with a standard methodology is to provide a standard method to assess PICO2, to 
be discussed next. PICO2 is a practical measure of hypercapnic dose in a suit environment. PICO2 
as hypercapnic dose is applicable to all subjects. It comes before PACO2 or PaCO2 and so is not 
modified by the individuals’ ventilatory response to hypercapnia. Thus, PICO2 is superior to 
PCO2 for development of CO2 limits in a space suit. 
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5.0 DEFINING A PRACTICAL HYPERCAPNIC DOSE 
 We avoid discussing CO2 concentration as a percentage and instead use dry-gas PCO2 as 
mmHg. We also frequently refer to the inspired wet-gas PICO2, PACO2, and PaCO2. The action of 
CO2 in the central nervous system is through the partial pressure of CO2 and resulting change in 
[H+] within the cerebrospinal fluid (PCSFCO2).     
 Atmospheric CO2 eventually reaches the lung. During this transition, the inspired gas 
becomes saturated with water vapor at 37°C, a PH2O of 47 mmHg or 0.909 psi since 1 psi = 51.7 
mmHg (Conkin 2011). The following 4 related equations are helpful: 
1.  FICO2 = PCO2/PB, where FICO2 is the dry-gas decimal fraction of CO2, PCO2 is dry-
gas atmospheric CO2 partial pressure as mmHg from a sensor, and PB is atmospheric 
pressure absolute as mmHg.  
2.  PICO2 = (PB–47) × FICO2, where 47 is the vapor pressure of H2O as mmHg at 37°C 
body core temperature. 
3.  FICO2 = PICO2/(PB–47) 
4.  PCO2 = PB × [PICO2/(PB–47)] or PB × FICO2 
 The critical explanatory variable for physiologic, neurocognitive, and performance 
responses is PaCO2, which is assumed equivalent to PACO2 in a healthy astronaut. Therefore the 
transition from dry-gas PCO2 in the breathing atmosphere to water saturated PICO2 at 37°C in 
the lungs is necessary for a precise dose-response approach to inspired CO2, much the same as 
for PIO2 in terms of hypoxic dose (Conkin 2016).  
 Figure 1 shows that for the same dry-gas PCO2, say 20 mmHg, the appropriate “dose” of 
CO2 transferred to arterial blood depends on the ambient pressure, in this case the space suit 
pressure. At 4.0 psia suit pressure (207 mmHg) a PCO2 of 20 mmHg equates to a PICO2 of 15.5 
mmHg while at 6.0 psia suit pressure (310 mmHg) the same PCO2 is a PICO2 of 17.0 mmHg. At 
sea level a PCO2 of 20 mmHg is a PICO2 of 18.76 mmHg. The ultimate goal is to define the 
equivalent PICO2 hypercapnic dose at any pressure. For example, to compute the equivalent 
PICO2 of 15.5 mmHg at 4.0 psia for sea level pressure, the PCO2 must be 16.52 mmHg, through 
Eq. 4 (above). Once an acceptable limit for PICO2 is established, then the PCO2 limit is 
computed for any suit pressure. Note that a PCO2 limit defined from testing at sea level will 
always produce a lower PICO2 when applied at reduced pressure. For example, an 8 mmHg 
PCO2 suit sensor limit at 14.7 psia (760 mmHg) results in a PICO2 of 7.5 mmHg. The same 8 
mmHg PCO2 suit sensor limit at 4.3 psia (222 mmHg) results in a lower PICO2 of 6.3 mmHg. 
Therefore, a practical measure of hypercapnic dose should be PICO2. It is reasonable to expect 
that the same PICO2 under different test conditions will produce the same performance outcomes 
in those conditions, within a reasonable range of PICO2.        
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Figure 1  Dry-gas PCO2 measured with a sensor that monitors the atmospheric 
breathing gas becomes saturated with water vapor on the way to the lungs. 
PICO2 at 760 mmHg for PCO2 of 5, 10, 15, and 20 mmHg are 4.7, 9.3, 14.0, 
and 18.7 mmHg, respectively.      
 
6.0 BASIC PHYSIOLOGIC RESPONSE TO BREATHING CARBON DIOXIDE 
 Figure 2 (White 1954) shows how an increase in the dry-gas decimal fraction of CO2 
(FICO2) at sea level increases the PICO2 and therefore the PACO2 (on y-axis) and in-turn the 
PaCO2 that stimulates physiologic responses to hypercapnia. At 0% FICO2 (0 mmHg PCO2), the 
PACO2 is normal at 40 mmHg. At an FICO2 of about 4% (30 mmHg PCO2), the PICO2 is 28.5 
mmHg and when combined with the CO2 in the alveoli then becomes a PACO2 of about 45 
mmHg. A small increase in PaCO2 even while breathing 1% and 2% CO2 is expected along with 
a small decrease in arterial blood pH (Ellingsen, Sydnes et al. 1987), (Brackett Jr, Cohen et al. 
1965). Ellingsen explained that the increase in V̇E provides only incomplete compensation for 
exposure to CO2 since PaCO2 remains above normal during the event. In other words, the body 
does not hyperventilate past what is needed to manage an increase in PaCO2, so some increase in 
PaCO2 is accomodated even when breathing a low level of CO2 (Jones, Levine et al. 1971). What 
is not seen on Figure 2 is the increased rate and depth of respiration in response to the increased 
hypercapnia.  
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Figure 2  An increase in the dry-gas decimal fraction of CO2 (FICO2) at sea level 
increases the PACO2 that initiates physiologic responses.  
  
 Figure 3 (Roth 1968) appears in many sources to describe a normal response to breathing 
CO2 at sea level in resting subjects. Note the wide variability to human response in pulse rate, 
respiration rate, and V̇E even when breathing air free of CO2. These measures and variability in 
the measures increase when breathing CO2, particularly when exceeding 2% (PCO2 = 15.2, 
PICO2 = 14.2 mmHg at sea level).   
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Figure 3  Large sample population response to breathing CO2 while resting at sea level. 
Range of standard deviation about the response variable is a measure of 
between-subject variability. 
 The single best description of the basic physiologic response to breathing CO2 comes 
from a classic 1955 publication by Rahn and Fenn (Rahn and Fenn 1955). A brief example is 
provided for the case of a resting person breathing CO2. Then an example is provided to compare 
and contrast a ground-based exposure with a person breathing air at 4.3 psi above sea level in a 
space suit (19.0 psia) and a person breathing 100% O2 at 4.3 psia, both breathing a PICO2 of 20 
mmHg. 
 Figure 4 (Rahn and Fenn 1955) shows equilbrium PACO2 (y-axis) and PAO2 (x-axis) for a 
person at rest breathing CO2. The curve that intersects the R (Respiratory Exchange Ratio [RER] V̇CO2/V̇O2) isopleths quantifies the resulting V̇A in response to breathing CO2. At sea level 
(normoxia), the PIO2 is 150 mmHg (point H). On the RER isopleth of 0.8 the PACO2 is 40 
mmHg with a resulting V̇A of 1.73 L(BTPS)/min. A vertical line from this point to the x-axis shows 
the normal PAO2 of about 100 mmHg for this resting, equilibrium condition. If V̇A was infinitly 
large, PACO2 would decrease to 0 mmHg and PAO2 would equal the PIO2 of 150 mmHg (point H 
again). Notice that as PICO2 increases the V̇A curve dramatically increases and PACO2 
equilibrates at a higher value. We are only concerned with point G because the upper limit for 
PICO2 breathing during an EVA will not likely exceed 20 mmHg [PICO2 = (PB–47) × FICO2], 
where FICO2 at point G is 0.028 and PB is 760 mmHg. Point B shows that PACO2 will increase 
from 40 mmHg to about 41 mmHg with a resulting increase in V̇A from 1.73 to about 3.0 
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L(BTPS)/min if RER is 0.8. Even if RER is 1.0 the PACO2 increases to 42 mmHg with V̇A of about 
3.5 L(BTPS)/min. Notice in this case that PAO2 increases from about 100 mmHg without breathing 
CO2 to about 125 mmHg when breathing a PICO2 of 20 mmHg. The increase in V̇A in response to 
a small increase in PACO2 has effectively shifted the equilibrium point in the lung to allow for a 
higher PAO2. 
 
 
Figure 4  Effect of inspiring CO2 on PACO2 (y-axis) and PAO2 (x-axis) over a range of 
R (RER) under steady-state conditions while at rest. Solid curve for alveolar 
ventilation rate: ?̇?𝐕A = 1.73 × (0.4 × PCO2 – 15). The 2.8% inspired CO2 is PIO2 
of 20 mmHg. Examples are provided using PAO2 = [PIO2 × RER + PACO2 × 
[FIO2 × (1 – RER)] + PICO2 – PACO2]/[FICO2 × (1- RER) + RER] from (Rahn 
and Fenn 1955). In the first example RER is 0.8, PACO2 is 40 mmHg, FIO2 is 
0.210, FICO2 is 0 at sea level, providing a PICO2 of 0 mmHg, PIO2 at sea level 
breathing air is about 150 mmHg, with a resulting computed PAO2 of about 
102 mmHg, as seen on the x-axis above by extending a vertical line from 
point A. In the second case, RER is still 0.8. PACO2 has increased to 42 
mmHg given an FICO2 of 0.028 at sea level, providing a PICO2 of 20 mmHg. 
The resulting FIO2 is 0.204; PIO2 at sea level, breathing air containing CO2 is 
about 145 mmHg. The resulting computed PAO2 of about 119 mmHg, as seen 
on the x-axis above by extending a vertical line from point B. 
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 Summary data from 1955 in Tables 1 and 2 are from Alexander (Alexander, West et al. 
1955) to show the typical physiologic responses to hypercapnia. Twelve resting subjects (3 
females) breathed 0%, 3%, and 5% CO2 for about 28 minutes. We assume the experiment was 
done at sea level pressure so the PICO2 was 0, 21.4, and 35.6 mmHg, respectively. Steady-state 
respiratory measurements and arterial blood were taken after 25–35 minutes. 
Table 1. Means and Standard Deviations of Respiratory Data from Resting Condition 
 
PICO2 
mmHg 
f 
breaths 
/min 
VT 
mL(BTPS) 
/min 
V̇E 
L(BTPS) 
/min 
V̇A 
L(BTPS) 
/min 
 V̇A * 
 
 
VD 
mL(BTPS) 
 
 
VD/VT** 
0 
σ(n-1)  
15.5 
5.0 
412 
103 
5.90 
1.00 
3.47 
0.50 
3.58 162 
27 
0.39 
21.4 
σ(n-1) 
19.4 
5.4 
651 
202 
11.64 
1.91 
7.67 
1.40 
7.79 215 
70 
0.33 
35.6 
σ(n-1) 
20.8 
6.0 
962 
291 
18.84 
4.13 
13.13 
2.85 
13.40 278 
125 
0.29 
*computed by Conkin from mean data, independent of author. 
** from means of VD and VT. 
V̇A = V̇E × [1 – VD/VT] 
Table 2. Means and Standard Deviations of Remaining Data from Resting Condition 
 
PICO2 
mmHg 
V̇O2 
mL(STPD) 
/min 
V̇CO2* 
mL(STPD) 
/min 
 
 
RER 
 
PaCO2** 
mmHg 
PaCO2 
mmHg 
 
 
 
pHa 
PAO2 
mmHg 
 
0 
σ(n-1) 
213 
33 
167 
26 
0.78 
0.05 
41.5 
2.4 
41.5 7.42 
0.016 
96.5 
4.2 
21.4 
σ(n-1) 
221 
39 
184 
25 
0.83 
0.09 
43.6 
2.10 
42.1 7.40 
0.012 
117.2 
3.2 
35.6 
σ(n-1) 
234 
51 
182 
38 
0.77 
0.05 
46.5 
1.83 
47.5 7.38 
0.017 
125.0 
2.6 
*based on V̇O2 × RER. 
**from arterial blood sample. 
PaCO2 = (V̇CO2/V̇A) × 863 + PICO2 
 P
A
O
2
 = [P
I
O
2
 × RER + P
A
CO
2
 × [F
I
O
2
 × (1 – RER)] + P
I
CO
2
 – P
A
CO
2
]/[F
I
CO
2
 × (1- RER) + RER], 
given PACO2 = PaCO2. 
 12 
 
 The first point is that variation in human response to increasing hypercapnia is evident in 
the increase in standard deviation across most measurements. The author did not show how 
physiologic dead space volume (VD, mL(BTPS)) was calculated but probably through VT × 
[(PaCO2 – PETCO2)/(PaCO2 – PICO2)] – VDvalve (the 60 mL dead space of the breathing valve) 
since arterial blood was sampled. PETCO2 is end-tidal CO2 partial pressure. VD increased from 
about 160 mL to 280 mL in resting subjects breathing 5% CO2. He mentions in the Discussion 
that his results about VD have “long been recognized”. So increase in VD with comparable 
increase in VT is observed in hypercapnic resting subjects and also in subjects that exercise while 
hypercapnic, see (Clark, Sinclair et al. 1980). But notice that the ratio of VD to VT, called wasted 
ventilation, decreased from 0.39 to 0.29. Wasted ventilation from another source (Murray 1986) 
for a resting subject breathing air is about 0.25, and computed from [(PaCO2 – PETCO2)/PaCO2], 
where PaCO2 is 40 mmHg and PETCO2 is 30 mmHg. It appears that VD increases and VD/VT 
decreases in hypercapnic resting subjects and in subjects that exercise with increasing CO2, at 
least in data from Clark. The reasons offered for an increase in VD include both a greater number 
of well ventilated alveoli and poorly perfused alveoli due to the vasoconstrictive action of CO2 in 
the pulmonary vasculature, both related to alterations in V̇A/Q̇. 
 Table 3 shows a comparison of estimated pulmonary gas partial pressures in a resting 
person breathing air in a space suit pressurized to 4.3 psi above sea level (19.0 psia) and a resting 
astronaut breathing 100% O2 at 4.3 psia, both breathing a PICO2 of 20 mmHg. Even though 
PICO2 is the same in both cases, the gases within a representitive “perfect” alveolus are different. 
Note that RER is 1.0 for the astronaut because in 100% O2 there is no N2 dilution effect possible. 
The N2 dilution effect is described in detail elsewhere (Rahn and Otis 1949), (Rahn and Fenn 
1955) and is only summarized here. When breathing 100% O2, however, many molecules of O2 
are taken out of the blood and an equal number is free to flow in from the trachea to maintain 
equality of pressure. While breathing 100% O2, the RER is 1.0 even if one hyperventilates 
(hypocapnia) or hypoventilates (hypercapnia). The combined PAO2 and PACO2 pair is set by the 
ratio of V̇A to V̇CO2 and will always be on the 1.0 RER isopleth. However, when breathing a gas 
with an inert gas component, the removal of O2 by the blood causes an equal volume of gas to 
flow from the trachea to maintain equality of pressure; however, this volume contains a fraction 
of inert gas. Partial pressures of all gases present (PACO2, PAN2, PAO2, PAAr, PAH2O) must sum 
to the total ambient pressure (Dalton’s Law of Partial Pressures). Because of the dilution, there is 
a unique RER for the unique PAO2 and PACO2 pair depending on the volume of O2 taken into the 
blood and the CO2 delivered from the blood. Even though the pulmonary gas partial pressures 
differ in Table 3 because absolute pressures are 4.5 times different, the PACO2s only differ by 1 
mmHg as estimated from Figure 4. In both cases, PAO2 is slightly hyperoxic and would have 
minimum impact on ventilatory response to hypercapnia. At least in the resting case, we 
conclude that a PICO2 of 20 mmHg during EVA at 4.3 psia will not create a physiologic response 
significantly different when compared to the extreme of testing on Earth at 19 psia. The case of 
hypercapnic exercise is covered next and followed by the case of hypercapnic exercise and 
adaptive changes in µG.  
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Table 3. Alveolar Gases at Rest for Ground Test and for EVA with PICO2 of 20 mmHg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From: P
A
O
2
 = [P
I
O
2
 × RER + P
A
CO
2
 × [F
I
O
2
 × (1 – RER)] + P
I
CO
2
 – P
A
CO
2
]/[F
I
CO
2
 × (1- RER) + RER], 
where FICO2 is either 0.021 for the 19.0 psia case or 0.114 for the 4.3 psia case, both providing a PICO2 of 
20 mmHg. For reference, PIO2 at sea level breathing air is about 149 mmHg with a resulting PAO2 of about 
103 mmHg. V̇A = 1.73 × (0.4 × pCO2 – 15). 
  
  Ground Test – 1G Standing 
19 psia (982 mmHg) 
20.0% O2 + 77.9% 
N2+Ar + 2.1% CO2 
EVA - µG 
“free-falling” 
4.3 psia (222 mmHg) 
88.6% O2  
+ 11.4% CO2 
Total pressure (PB) 
Σ PAx 
982 mmHg 222 mmHg 
PICO2 20 mmHg 20 mmHg 
PIO2 =   187 mmHg  155 mmHg 
PAO2 ≅ 163 mmHg 133 mmHg 
PACO2 ≅ 41 mmHg 42 mmHg 
PAH2O =  47 mmHg 47 mmHg 
PAN2 ≅  731 mmHg 0 mmHg 
RER 0.85 1.0 
?̇?𝐕A  ≅  
(BTPS) 
2.4 L/min 3.1 L/min 
gas density 
PAN2 
greater 
not equilibrated 
lesser 
near equilibrated 
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7.0 OXYGEN AND CARBON DIOXIDE INTERACTIONS 
 Changes in PO2 combined with changes in PCO2 at rest and during exercise have 
complex physiologic interactions to set ventilation and cardiovascular responses because both O2 
and CO2 stimulate peripheral and central chemoreceptors differently (Dahan, DeGoede et al. 
1990), (Lambertsen, Hall et al. 1963), (Ainslie and Duffin 2009), (Ainslie and Poulin 2004), 
(Koyal, Whipp et al. 1976). The control of V̇A, and by extension V̇E, depends on PaCO2, PaO2, 
and arterial H+. An important feature of the blood-brain barrier is the low permeability to ions 
such as H+ and HCO3- and high permeability to lipid-soluble molecules such as CO2. This 
selective permeability dictates how ventilation changes in response to changes in PaO2, PaCO2, 
and H+ with peripheral chemoreceptors primarily responsive to changes in PaO2 and H+ and 
central chemoreceptors exquisitely responsive to PaCO2 and H+. Hyperoxia stimulates increased 
ventilation (Becker, Polo et al. 1996), (Dean, Mulkey et al. 2004); however, those details are not 
relevant to review here because the EVA environment is near-normoxic. However, the extent of 
the hyperoxic-induced hyperventilation is attenuated by a decrease in PaCO2 caused by the 
hyperventilation, so is somewhat self-correcting. But hypercapnia would add to the hyperoxic-
induced increase in ventilation. Ainslie (Ainslie and Poulin 2004) presents a comprehensive 
study in resting subjects where ventilation, CBF, and mean arterial pressure (MAP) are evaluated 
from hypoxia to hyperoxia combined with normal and hypercapnic PETCO2. Slopes of 
ventilation, CBF, and MAP responses with arterial blood O2 saturation (SPO2) were greater in 
hypercapnia. The following case is made to argue that hyperoxia during EVA is minimal with 
regard to the control of ventilation. 
 A significant amount of basic physiologic and applied research has been done by the 
military to describe combined hyperoxia and hypercapnia because hyperoxic rebreather systems 
tend to accumulate CO2 during energetic diving. For example, Gill (Gill, Natoli et al. 2014) 
showed a protective effect of high PO2 (989 mmHg) against symptoms of PCO2 up to 65 mmHg 
as compared to a normoxic PO2 of 160 mmHg. The increase in V̇E associated with hyperoxia 
resulted in less PETCO2 during rest or exercise irrespective of hypercapnia. Fothergill (Fothergill, 
Hedges et al. 1991) examined the interaction of hypercapnia and increased PIN2 thinking that the 
threshold for N2 narcosis would decrease with hypercapnia – it did not. They concluded that high 
PETCO2 and PIN2 are additive in their effects on impaired cognitive and psychomotor 
performance in resting subjects. Results from both Gill and Fothergill are confounded in that Gill 
did not control for N2 narcosis at 6 ATA and Fothergill did not control for hyperoxia at 6 ATA. 
Fortunately, neither of these issues are relevant during EVA.    
 In relation to specific EVA or LEA conditions, the difference in PIO2 between breathing 
air at sea level and breathing 100% O2 during EVA at 4.3 psia is only about 25 mmHg (175 
mmHgEVA – 150 mmHgsea level). This small difference will not significantly modify response 
variables (Henning, Sauter et al. 1990), (Sheehy, Kamon et al. 1982), (Vercruyssen, Kamon et al. 
2007), (Lambertsen, Hall et al. 1963) over our limited PCO2 range from 0 to 20 mmHg and 
exercise from 250 to 2,500 mL(STPD) O2/min as seen in Figure 5. Literature data regarding 
hypercapnia during rest and exercise with near-normoxic PIO2 will apply without modification to 
EVA and LEA conditions. 
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Figure 5 Increase in ?̇?𝐕E as PaCO2 increases in hypoxic or hyperoxic conditions, from 
(Lambertsen, Hall et al. 1963). ?̇?𝐕E in response to an increasing PaCO2 is not 
significantly increased as PACO2 increases from normoxic (118 mmHg) to 
hyperoxic (648 mmHg) condition. However, the combination of hypoxic 
PAO2 (43 mmHg) with increased PaCO2 dramatically increases ?̇?𝐕E.             
 We conclude from this section that the difference between an exposure with a PIO2 of 
about 145 mmHg using room air diluted with CO2 and an exposure with a PIO2 of 175 mmHg 
(EVA-like) with 100% O2 at 4.3 psia mixed with CO2 will not significantly impact adequate O2 
delivery to tissues nor will it significantly hinder CO2 removal from tissues. Hb will be nearly 
saturated (98%) with O2 under either condition. CO2 transport by Hb from tissues will not be 
significantly influenced by O2 binding onto Hb over the range of our EVA conditions. The use of 
normoxic or even mildly hyperoxic breathing gas will not hinder the ability of Hb to deliver O2 
to the tissues given mild hypercapnia nor to transport CO2 from the tissues given mild 
hypercapnia because the allosteric Hb molecule is adaptive and CO2 transport is not solely tied to 
Hb. 
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8.0 HYPERCAPNIA AND MANAGEMENT OF HYDROGEN IONS  
 Much is known about acid-base regulation through rapid respiratory and slower renal 
compensations. The goal is to preserve a normal alkaline pH of 7.4, within a range from 7.0 to 
7.8 compatible with life. The combination of hypercapnia and exercise is a challenge to the 
buffering and compensation mechanisms. For a complete treatment about whole-body buffering 
of H+ in response to hypercapnia consult Valtin (Valtin 1983), his Figure 9-7 in 2nd edition. In 
simple terms, the blood in the pulmonary capillaries in the presence of hypercapnia responds the 
same way as the blood in the systemic capillaries in terms of H+ buffering and CO2 transport; 
however, the ultimate goal is to remove CO2 from the tissues and not to transport CO2 to the 
tissues. Hb and the red blood cell (RBC) is uniquely suited to deliver O2 and remove CO2 in 
concert with H+ buffering, even when modified by the presence of hypercapnia combined with 
exercise.  
 Hb is a large (64,500 Daltons molecular weight) 4-chain polypeptide allosteric protein. 
The 2 α-chains and 2 β-chains each contain an iron porphyrin heme ring able to reversibly bind a 
molecule of O2 while CO2 binds reversibly at the N terminus valines of both α and β chains. As 
each O2 molecule binds to Hb, it increases the affinity of the remaining heme sites for additional 
O2 molecules, which results in the nonlinear S-shape of the O2 dissociation curve. Metabolically 
produced carbon monoxide (CO) does compete for heme sites and has 250 times the affinity for 
these sites compared to O2 (carboxyhemoglobin). Also a small fraction of heme sites contain iron 
in a ferric (Fe III+) form instead of the normal ferrous (FE II+) form, so they cannot bind O2 
molecules (methemoglobin). The affinity of Hb for O2 is modified by several factors (ligands): 
H+, CO2, temperature, and 2-3-diphospoglycerate. All substances that exert an interdependent 
effect on the chemical binding properties of Hb are termed ligands. This means that the 
concentration within RBCs of any ligand affects the ability of Hb to combine with the remaining 
ligands. Then there are the interactions between Hb and NO and how these interactions result in 
enhanced perfusion when Hb delivers O2 to the tissues  – clearly complex interactions occur 
(Yonetani, Park et al. 2002), (Stamler, Jia et al. 1997) that are too numerous to summarize here. 
 Refer to Figure 6 for this discussion. At the systemic capillaries, CO2 diffuses from the 
tissue into the plasma and into the RBCs. Very little CO2 is converted to HCO3- in the plasma, 
and the H+ that is released is buffered by nonbicarbonate plasma buffers. A small amout of CO2 
is dissolved in the plasma and RBCs, which is removed at the pulmonary capillaries through 
diffusion. The majority of CO2 from rest or exercise is converted to HCO3- within the RBC by 
the action of intracellular carbonic anhydrase (CA). This HCO3- is transported into the plasma as 
a chloride ion (Cl-) is transported into the RBC through a membrane ion exchange pump. CO2 
within the RBC also binds to Hb, now called carbamino Hb, and the release of H+ from this 
reaction and the release of H+ from the CA reaction are taken up (buffered) by Hb. A 
conformational change to Hb as a result of H+ binding reduces O2 affinity for Hb and enhances 
the removal of O2 for use by the tissues. These processes are then reversed in the pulmonanry 
capillaries. The binding of O2 to Hb in the pulmonary capillaries results in the displacement of 
bound CO2. With the aid of CA in pulmonary endothelial cells, the HCO3- in the venous blood is 
reconverted to CO2 and removed by respiration. Thus the methods by which Hb handles O2 and 
CO2 reciprocally augment the uptake and release of both gases in the lungs and tissues (Murray 
1986), (Hlastala and Berger 2001). 
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Figure 6 The transport of CO2 and buffering of H+ by the blood, from Figure 9-2 
in (Valtin 1983). 
 
Any physiologic description of CO2 uptake, transport, and removal requires at least a 
brief description of CA. Enzymes increase the rate of reactions. If CA was not present, then the 
amount of transportable CO2 as HCO3- would be inadequate to meet metabolic production of 
CO2, leading to hypercapnia (Hlastala and Berger 2001). CA in its many isozyme forms, is 
located in RBCs, on all capillary endothelium, in the kidney, brain, and other tissues. CA 
facilitates the conversion of CO2 to HCO3- (hydration reaction) and HCO3- to CO2 (dehydration 
reaction), depending on its location in the tissues and the prevailing reactant concentrations. 
Much has been learned about the role of CA through blocking its action with acetazolamide and 
benzolamide. CA makes the carriage and evolution of CO2 possible across small gradients, 
otherwise large PCO2 gradients form in tissues and the lung (Swenson and Maren 1978). In brief, 
inhibiting CA leads to an increase in V̇E, mostly through an increase in VT and not an increase in 
breathing frequency (f). The drive to increase V̇E is through an immediate tissue respiratory 
acidosis as CO2 is retained in all tissues and a slower metabolic acidosis due to renal HCO3- 
diuresis through inhibition of CA in the kidneys. The increase in CO2 in place of HCO3- and the 
increase in H+ are sensed by central chemoreceptors leading to the increase in V̇E as a 
compensation to augment CO2 removal (Ringelstein, Van Eyck et al. 1992). It is a common 
clinical practice to breathe CO2 as a means to monitor cerebral vasomotor reactivity in those with 
compromised cerebral circulation (Leaf and Goldfarb 2007). Hypercapnia induces vasodilation 
of the mid-cerebral artery (MCA), which is also achieved through inhibiting CA with 
acetazolamide. 
In the case of hypercapnia, the blood in the pulmonary capillaries is “forced” to respond 
the same as the blood in systemic capillaries, which is clearly inefficient because the goal is to 
remove CO2 from the body and not transport CO2 to the body. Excess CO2 would be transported 
to the tissues to add to what is produced by the tissues, an additional burdon to CO2 removal and 
H+ buffering. The H+ produced from the CO2 of hypercapnia cannot be buffered by the 
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bicarbonate system. When H+ is buffered by HCO3- the carbonic acid (H2CO3) formed quickly 
dissociates back to CO2 and H2O. Because CO2 and H2O are the starting substrates, when CO2 is 
added to the body, the reaction H+ + HCO3-  H2CO3  CO2 + H2O is being driven to the left, 
and cannot simultaneously be driven to the right as would be required if the H+ were to be 
buffered by HCO3-. Instead, the H+ must be buffered by the nonbicarbonate buffers available to 
the body, in particular Hb. A large proportion of the added volatile acid is buffered by RBCs, 
which rapidly convert the added CO2 to HCO3- carried in the plasma to the tissues. Lambertsen 
(Lambertsen, Hall et al. 1963) clearly shows the increase in venous bicarbonate concentration 
[HCO3-]v as PaCO2 increases during hypercapnia.  
 In summary, CO2 is transported in venous blood in physical solution (6%), bound to 
proteins that include Hb (carbamino, 7%), and as HCO3- (87%) through the action of CA within 
the RBCs (Klocke 1987). Increased CO2 reduces O2 affinity for Hb even though there is not a 
direct competition between CO2 and O2 for heme sites. Hb is an effective buffer to supplement 
other buffer systems in the body. When PaCO2 is increased or decreased, the changes in plasma 
HCO3- are not equal to changes in [H+] due to the action of Hb as a component of the total 
extracellular fluid compartment. The dissociation constant for Hb is 6.8 as compared to 6.1 for 
H2CO3 so is closer to normal pH and Hb O2 saturation alters the buffering capacity of Hb. When 
PO2 is low in the systemic capillaries the affinity for H+ is high and is reversed in the pulmonary 
capillaries where PO2 is high. The proton released from the hydration of CO2 through CA is 
buffered by Hb, and the resulting HCO3- moves into the plasma in exchange for Cl-. Hb is less 
efficient at removal of CO2, H+ buffering, and O2 transport when CO2 is provided externally, but 
additional buffer capacity is available to preserve pH. Excess arterial blood HCO3- eventually 
returns to the normal 24 mEq/L as excess CO2 is eventually exhaled when the hypercapnia is 
removed. This complex give-and-take can accommodate hypercapnia combined with exercise if 
either is not excessive and that astronaut physiology is otherwise normal. 
 Brackett (Brackett Jr, Cohen et al. 1965) exposed 7 resting men to 7% CO2 over 90 
minutes and then 10% CO2 on another day. Serial arterial blood samples showed the increase in 
PaCO2 and associated generation of HCO3- by body buffers, and the increase in [H+]a. All 7 
tolerated the 7% CO2 for the requested 40–90 minute exposure; however, all mentioned heavy 
breathing and some complained of mild headache and burning of eyes. During the 10% CO2 
exposure, hyperventilation was extreme and most subjects became restless and confused to the 
point where the experiment was discontinued earlier than planned. Brackett concluded that the 
increase of only 3 mEq/L HCO3- above the normal 24 mEq/L at a PaCO2 of 80 mmHg was a 
modest compensation for respiratory acidosis with pH still falling to 7.20; there was only a 
modest generation of HCO3- from endogenous buffer stores during this acute respiratory 
acidosis. The HCO3- buffer system alone is a poor buffer but, fortunately, other buffer systems, 
such as the Hb buffer system, have better buffer value to preserve pH and was active during this 
experiment. Over a range of PaCO2 from 40-50 mmHg in a resting EVA astronaut the [HCO3-]a 
would show a modest increase and pH would decrease from 7.4 to about 7.3. The preservation of 
pH during exercise combined with hypercapnia is covered later in greater detail through the work 
of other investigators (Clark, Sinclair et al. 1980), (Graham, Wilson et al. 1982), (Menn, Sinclair 
et al. 1970). 
  
 19 
 
9.0 BASIC PHYSIOLOGY OF EXERCISE COMBINED WITH HYPERCAPNIA 
 Figure 7 (Hlastala and Berger 2001) is used to introduce and summarize physiologic 
responses to normocapnic exercise, next we review hypercapnic exercise. The healthy body is 
exquisitely tuned to match cardiopulmonary response to exercise. As O2 consumption increases 
and CO2 production increases, V̇E and Q̇ increase to meet the demand. The control is so precise 
that PaCO2, PaO2, and [H+] remain stable over a large range of V̇O2 as shown in Figure 7. 
Exercise can be performed at different PBs and under different PO2 and/or PCO2. Rate and depth 
of respiration increase as PICO2 increases (Jacobi, Iyawe et al. 1987), (Reynolds, Milhorn et al. 
1972), which is integrated with an increase in heart rate (HR) and stroke volume (Dahan, 
DeGoede et al. 1990). The chemical control of breathing is an expansive topic and best left to a 
textbook on respiratory physiology (Hlastala and Berger 2001). Others even posit additional CO2 
sensing in the lung (Forster, Klein et al. 1982), but that diverts our focus. Also, the way the CNS 
integrates the increase in V̇E by increasing VT and f in response to exercise and hypercapnia is yet 
another layer of complexity; mainly through an increase in VT with an increase in f playing a 
lesser role (Sackner, Nixon et al. 1980), (Bussotti, Magrì et al. 2008), (Jones, Robertson et al. 
1979). This also diverts our focus and will not be covered in any detail. The simplest 
interpretation for the hypercapnic EVA case is that PaCO2 increases in response to respiratory 
and metabolic acidosis over a range of exercise possible during EVA, which is countered 
through several person-specific physiologic responses.    
    
 
Figure 7 Human responses to exercise. 
 Several publications regarding exercise combined with hypercapnia are available under 
different ambient pressure and PO2 conditions (see Table in Appendix) and provide information 
that can be extrapolated to exercise during a hypobaric EVA with astronauts breathing 100% O2. 
In particular, understanding the synergy between exercise and hypercapnia on the ventilatory 
response over the EVA range of PICO2 and V̇O2 is our goal.  
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 Exercise increases both the rate and depth of respiration and Q̇ in response to metabolic 
acidosis. Hypercapnia has the same effect working through respiratory acidosis, so both exercise 
and hypercapnia have a positive effect on ventilation and HR (Liu, Liu et al. 2015), (Koyal, 
Whipp et al. 1976), (Luft, Finkelstein et al. 1974). However, the increase in V̇E and HR, and 
other measures, with hypercapnia and exercise are not simply additive; there are interactions 
such that the combined effect is less than one might expect (Clark, Sinclair et al. 1980), (Poon 
and Greene 1985). In addition, there is a wide range of aerobic capacity in otherwise healthy men 
and women that would dictate performance under hypercapnic conditions (Bishop, Lee et al. 
1999). Clark showed that with more severe workload that increased CO2 sensitivity declined 
progressively as maximum ventilation was approached. Poon did not impose as severe 
workloads and showed that controlled hypercapnia enhances exercise hyperpnea by augmenting 
not only resting ventilation but also the ventilatory sensitivity to exercise. The resulting increase 
in slope and intercept of the V̇E–V̇CO2 curve were proportional to the rise in PaCO2. The body 
can accommodate for a short time the increase in PaCO2 caused by hypercapnia superimposed on 
exercise (Loeppky 1998), (Luft, Finkelstein et al. 1974). Just as you can temporarily reduce the 
body store of CO2 with conscious hyperventilation, you can increase the body store by 
rebreathing CO2 even while exercise is performed (Fan and Kayser 2013), his Figure 2, (Menn, 
Sinclair et al. 1970), his Table 5, and (Sinclair, Clark et al. 1971), his Figure 2.  
 The same control system that responds to hypercapnia also responds to increased PaCO2 
during exercise. Ventilation and perfusion are matched such that PaCO2 and pH are stable 
through a wide range of aerobic exercise. We expect respiration rate (RR), HR, VT, and V̇E to 
increase as PICO2 and O2 consumption increase. We expect PaCO2 to increase in a dose-response 
manner to the increase in PICO2. The combinations of exercise and increased PCO2 will be 
tolerated by astronauts based on the experiments described by Menn (Menn, Sinclair et al. 1970). 
Table 4 shows target metabolic rates possible during EVA given a PICO2 of 15 mmHg.  
Table 4. Estimated O2 Consumption and CO2 Production Rates Given PIO2 of 15 mmHg 
BTU/h kcal/min L(BTPS) V̇E/min* L(STPD) O2/min L(STPD) CO2/min 
300 
(resting) 
 
1.26 
 
13 
 
0.26 
 
0.22 
1000 4.2 31 0.86 0.73 
2000 8.4 53 1.72 1.46 
3000 12.6 75 2.59 2.20 
Computed O2 consumption and CO2 production based on the following: 100 BTU/h = 0.42 
kcal/min and at RQ = 0.85 there is 4.862 kcal/liter(STPD) O2.* Based on estimates from 
Menn (Menn, Sinclair et al. 1970) for PICO2 of 15 mmHg.  
Research by Krasnogor (Krasnogor, Wempen et al. 1968) in 1968 is noteworthy in that 
continuous modest ergometer work (100 watts at 60 rpm) for 3 hours with a PCO2 of 7.6 mmHg 
was done in a space suit-like environment, simulated in a hypobaric chamber at 180 mmHg (3.45 
psia, 35,000 ft altitude) with FIO2 of about 0.90 resulting in a PIO2 of 120 mmHg. Arterial blood 
gas, ventilation, and metabolic rate data indicated no significant impact of this acute mild 
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hypercapnic and mild exercise at altitude and no significant difference when compared to same 
protocol at 700 mmHg. The consumption of O2 was about 1.2 l (STPD)/min for each protocol with 
no significant change in PaCO2 of about 36 mmHg during the rest or exercise interval at 180 
mmHg or at 700 mmHg. Mean V̇E during exercise at 180 mmHg was about 34 l (BTPS)/min and 
mean arterial pH was never lower than 7.39 under all conditions. Arterial blood saturation (SaO2) 
was about 96% under all conditions. This was convincing evidence in 1968 that modest 
continuous work combined with modest hypercapnia could be performed under space suit EVA 
conditions. 
In general, V̇O2 and V̇CO2 during exercise are not changed by breathing CO2 when either 
exercise intensity or PICO2 is low (Fan and Kayser 2013). However, there are exceptions that we 
now summarize. Most agree that the increase in V̇O2 with exercise is not inhibited by 
hypercapnia. Menn (Menn, Sinclair et al. 1970) found a difference (change) in V̇CO2 but no 
difference in V̇O2 (change) with exercise at 2/3 V̇O2max and increasing hypercapnia. He 
attributed these findings to an increase in CO2 retention with hypercapnic exercise greater than 
1/2 V̇O2max. RER decreased as exercise intensity and PICO2 increased, also seen by Sinclair 
(Sinclair, Clark et al. 1971). Graham (Graham, Wilson et al. 1982) found similar results at 55% 
and 65% V̇O2max exercise in hypercapnia but attributed the decrease in RER to a shift in 
metabolism from carbohydrates to lipids due to combined respiratory and metabolic acidosis that 
decreased pH secondary to hypercapnia. Mean blood lactate under hypercapnic exercise was 
reduced from 3.88 mM/l to 2.22 mM/l while breathing 6% CO2 for 30 minutes at 65% V̇O2max. 
In contrast, Clark (Clark, Sinclair et al. 1980) provided convincing data for no difference 
(change) in V̇O2 or V̇CO2 with increasing hypercapnia. RER increased as V̇O2 increased with no 
modification (decrease) due to hypercapnia, as seen by others. Mean blood lactate increased as V̇O2 increased and was not modified (decreased) with hypercapnia, as seen by others. For 
example, at V̇CO2 of 3.0 L/min, blood lactate was about 5 mM/L over the range of blood-gas 
PaCO2 from 35 to 60 mmHg. 
Luft (Luft, Finkelstein et al. 1974) conducted a particularly detailed investigation relevant 
to hypercapnic exercise during EVA. The experiments were conducted in Albuquerque at a PB of 
about 632 mmHg (5,000 feet altitude). 12 men with mean age of 26.5 years breathed air and air 
with PICO2 of 15 mmHg during stepped bicycle ergometry to the point where they could not 
maintain a metronome pedaling rhythm that produced 50 rpm. The stepped protocol required 
about 15 minutes, then 30 minutes of recovery while still breathing the test gas. The main 
conclusion was that the combination of metabolic acidosis from anaerobic metabolism in leg 
muscles combined with incomplete compensated respiratory acidosis from hypercapnia taxed the 
respiratory response such that CO2 retention was evident. Hypercapnia resulted in a decrease in 
RER, an indication of CO2 retention. Blood gases were collected from 10 of the 12 men. Those 
breathing air showed a decrease in PaCO2 from 37 to 30 mmHg during exercise. Those breathing 
CO2 showed an increase from 36 to 41 mmHg during exercise with a critical rise in [H+]a. Both 
observations were similar to those reported by Clark (Clark, Sinclair et al. 1980); however, 
without an indication of CO2 retention. The inspired ventilation rate (V̇I) was about 45% greater 
in the hypercapnic subjects across the exercise profile until subjects reached the peak of their 
performance. Then V̇I converged to about the same 140 L(BTPS)/min. CO2 loading was most 
dramatic at this point where further increase in ventilation was no longer possible leading to 
acute respiratory acidosis at a point where metabolic acidosis was rapidly increasing. O2 
consumption and maximum work was less with CO2 in the last 2 minutes at work and during the 
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first minute of recovery. Clearly, the ventilatory compensation for hypercapnia combined with 
vigorous exercise was taxed. There was an increased V̇I relative to the controls at all points 
during the 30 minute recovery. There were no differences in serum electrolyte concentrations, 
even after corrected for the transient decrease in plasma volume due to exercise. 
10.0 HUMAN VARIATION IN RESPONSE TO HYPERCAPNIA 
 No two humans are physiologically the same, even within the same sex. So the same 
response to the same level of hypercapnia in different astronauts is not expected. For example, a 
PETCO2 range from 36 to 44 mmHg was measured in 9 resting subjects (Bloch-Salisbury, 
Lansing et al. 2000). Shea (Shea, Walter et al. 1987) measured a range from 29 to 42 mmHg for 
PETCO2 in 41 resting subjects, about half were women. It is well known that there is significant 
variation to the hypoxic ventilatory response (Teppema and Dahan 2010), (Ainslie and Poulin 
2004) as well as the hypercapnic ventilatory response (Prisk, Elliott et al. 2000), (Sebert, 
Barthelemy et al. 1990), (Jones, Levine et al. 1971). Responses to hypercapnia are subject-
specific (Lambertsen 1960, Laurie, Vizzeri et al. 2017, Law, Young et al. 2017), (Morelli, Badr 
et al. 2004), (Haywood and Bloete 1969), (Alexander, West et al. 1955), which in-turn extends to 
human variability in neurocognitive and performance responses during onset and recovery from 
hypercapnia superimposed on exercise. Between-subject variability in the acute hypoxic 
ventilatory response is linked to variability in CBF and MAP responses to hypoxia, which in-turn 
are sensitive to hypercapnia responses between subjects (Ainslie and Poulin 2004). Increasing 
age is associated with less ventilatory response to hypoxia and hypercapnia (Kronenberg and 
Drage 1973). Shea (Shea, Walter et al. 1987) documents a wide range of breathing pattern 
variability between resting subjects but reproducible breathing patterns within resting subjects. 
Schaefer (Schaefer 1958) noted that those with a lower f and larger VT also had a reproducibly 
higher PETCO2 and a lower ventilator sensitivity to hypercapnia, a potential basis to select for 
hypercapnia resistance. 
 Laurie (Laurie, Vizzeri et al. 2017), extending the work by Zwart (Zwart, Gibson et al. 
2012) on the mechanisms of ocular change in µG, suggests a specific genetic link as the basis for 
variations in PaCO2 between humans. Sebert (Sebert, Barthelemy et al. 1990) concluded from a 
single-breathe CO2 challenge that sensitivity (∆V̇E/∆PETCO2) to transient hypercapnia and its 
interaction with hyperoxia are weaker in women than in men, suggesting that hormonal status is 
the likely reason. A single-breathe CO2 challenge offers only limited insight into hypercapnia 
and gender response. In contrast, Haywood (Haywood and Bloete 1969) concluded in a study 
with steady-state hypercapnia in normobaric air that women’s ∆V̇E/∆PACO2 response averaged 
higher than in men as well as respiration rate when breathing 4 and 5% CO2. Otherwise healthy 
humans differ in their absolute aerobic capacity in response to exercise and therefore exercise 
response to hypercapnia (see Exercise Combined with Hypercapnia). We do not review the vast 
literature about human variation and accommodation to stressors. We do concede that a single 
space suit PCO2 limit will likely be too conservative for most and not conservative enough for a 
few. A program to identify those susceptible or resistant to hypercapnia could be operationalized 
rather than recommend a very low PCO2 limit that protects the most responsive astronaut. Those 
identified might be assigned easier EVA tasks, select greater helmet ventilation, have additional 
rest intervals during EVA, etc. How such a program is implemented is beyond the scope of this 
literature review.         
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11.0 MICROGRAVITY: INTRACRANIAL PRESSURE AND PULMONARY GAS 
EXCHANGE 
A host of changes occur to the human body as a consequence of spaceflight and exposure 
to µG, broadly classified as “space adaptation syndrome”. The EVA astronaut is not immune to 
these changes and may place the astronaut at greater risk of spaceflight-induced intracranial 
hypertension in the presence of hypercapnia (Michael and Marshall-Bowman 2015), (James, 
Meyers et al. 2011). Law (Law, Van Baalen et al. 2014), (Law, Watkins et al. 2010) contends 
that there may be greater sensitivity to and therefore consequences of hypercapnia in µG. An 
increased probability of headache with increased PCO2 may be an indicator of increased 
intracranial pressure (ICP) due to CO2-induced vasodilation and decreased venous drainage 
because of the loss of the hydrostatic gradient in µG. Laurie (Laurie, Vizzeri et al. 2017) 
investigated this hypothesis further but was limited to about 15 minutes of 6-degree head-down 
tilt (HDT) with subjects breathing 1% CO2 in air. Others have extended the duration and degree 
of HDT and even exposed subjects to 3% CO2. Marshall-Goebel (Marshall-Goebel, 2018) 
exposed 6 males to 12-degree HDT for 26 hours with and without 0.5% CO2. There was no 
difference in the increased right internal jugular blood volume when 12-degree HDT was 
combined with 0.5% CO2 over several hours. She showed no increase in ICP in 9 males 
subjected to 3.5 hours of 12-degree HDT while breathing 1% CO2 (Marshall-Goebel, Mulder et 
al. 2017). Kurazumi (Kurazumi, 2018) concluded with 15 males that the addition of 3% CO2 and 
10-degree HDT for 10 minutes did not increase ICP compared over the increase just due to 10-
degree HDT. PETCO2 increased about 6 mmHg during the brief hypercapnia but the increased 
ICP was mainly induced by cerebral fluid shift with 10-degree HDT. Just the simple act of 
transitioning from supine to standing posture in 1G influences the PACO2–PAO2 point and 
respiratory mechanics (Rahn and Fenn 1955) (see Figure 8).  
 
Figure 8  At sea level, breathing air at rest PAO2 increases from 100 to about 
105 mmHg as PACO2 decreases from 41 to 36 mmHg during the 
transition from supine to standing posture in 1G.   
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Now there is good evidence that pulmonary gas exchange is not hindered despite the 
significant physiologic changes as part of µG adaptation. Much has been learned about gas 
exchange physiology in µG (Prisk GK 2013). Pulmonary diffusion capacity (DLCO) from single-
breath CO breathing and membrane diffusing capacity (Dm) both increase to parallel the increase 
in pulmonary capillary blood volume (Vc) in µG. The persistent increase in DLCO and Dm is 
evidence that pulmonary edema does not occur in µG. In addition, gravity imposes a degree of 
matching between ventilation and perfusion. Prisk concluded that, “… the increases (DLCO, Dm, 
and Vc) rapidly revert to preflight levels on return to 1g. This in-flight increase was attributed to 
a transition of the pulmonary circulation from a 1g configuration (ie, zones 1, 2, 3) to a situation 
in which the lung vasculature is entirely zone 2 or 3. This would result in more uniform filling of 
the pulmonary capillary bed and an attendant increase in the surface area available for gas 
exchange”. So an otherwise normal lung with no change in the apparent range of V̇A/Q̇ in µG is 
expected to have no impediment to gas transfer (Prisk, Elliott et al. 1995, Prisk, Elliott et al. 
2000, Prisk, Fine et al. 2006) (Conkin, Wessel et al. 2017). However, this does not mean that 
hypercapnia does not increase pulmonary vascular resistance (Balanos, Talbot et al. 2003). The 
ventilatory response to changes in PaO2 and PaCO2 are mediated through peripheral and central 
chemoreceptors. In addition to these controls for ventilation, local pulmonary vasculature is 
modulated through variations in both PCO2 and PO2 as part of V̇A/Q̇ matching. Smooth muscle in 
the pulmonary arterioles contract during hypercapnia and hypoxia and relax during hypocapnia 
and hyperoxia (Sheehan and Farhi 1993). Balanos (Balanos, Talbot et al. 2003) concludes that 
CO2 is a more important regulator of pulmonary blood flow than O2. The neural activity of 
peripheral chemoreceptors are also influenced by arterial pressure and adaptation to µG modifies 
blood pressure. Prisk (Prisk, Elliott et al. 2000) concluded that an increase in blood pressure 
detected by the carotid baroreceptors in µG resulted in a large reduction of the hypoxic 
ventilatory response (similar to that seen from supine position in 1G) but that the hypercapnic 
ventilatory response was unaltered in µG. The opposite vascular response between the 
pulmonary and systemic circulations in response to both PO2 and PCO2 is logical and 
wonderfully complex. It is linked to the transition from life in water to life in air during 
mammalian birth, an evolution that required millions of years to perfect (Swenson 2013). 
Under EVA conditions we are not concerned about ventilatory response to hypoxia since 
hypoxia is not present and there appears to be no additional change in ventilatory response to 
hypercapnia in µG. There are measurements of elevated PETCO2 in µG, attributed to 
hypoventilation secondary to a cephalad shift of abdominal contents, rebreathing CO2 from the 
ISS atmosphere, or a physiologic change in ventilatory sensitivity to CO2 (Hughson, Yee et al. 
2016). Our literature review is not exhaustive on this subject. But we conclude that an otherwise 
healthy EVA astronaut can efficiently exchange O2 and CO2 through the lung during rest and 
exercise even if the mechanics (strategy) of breathing are slightly modified in µG (Prisk, Elliott 
et al. 1995). 
Deconditioning in µG and exercise countermeasures to reduce deconditioning combined 
with exercise response to hypercapnia is beyond the scope of this literature review for the EVA-
specific condition. We have no recommendations about PICO2 under chronic conditions to either 
enhance or retard exercise countermeasures to manage deconditioning in µG. 
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12.0 EXTRAVEHICULAR ACTIVITY FUNCTIONAL AND COGNITIVE DOMAINS: 
THE BRAIN AND HYPERCAPNIA  
 Before proceeding with details, a 2016 comprehensive literature review by Stankovic 
(Stankovic, Alexander et al. 2016) titled, “A Review of Cognitive and Behavioral Effects of 
Increased Carbon Dioxide Exposure in Humans” concludes, “While many studies have thus far 
addressed the impact of CO2 concentration on cognition, the inconsistent and contradictory 
nature of current findings limits the ability to draw firm conclusions about the impact of elevated 
CO2 exposure on sleep, cognition, and psychomotor performance. Further research, therfore, 
remains necessary to provide a clearer understanding of the risks of adverse cognitive and 
performance effects of acute and chronic high CO2, particularly at levels relevant to human 
spaceflight.”  
 Recent studies about air quality in public spaces, such as offices and schools, suggest that 
neurocognitive function, as measured through computer-based assesment programs, is reduced at 
PCO2 slightly greater than outdoor air (Satish, Mendell et al. 2012), (Allen, MacNaughton et al. 
2016), (Bakó-Biró, Clements-Croome et al. 2012), on the order of 1 mmHg PCO2. Increasing the 
ventilation in school class rooms decreased PCO2 from about 1.1 mmHg to 0.34 mmHg (outdoor 
air is 0.23 mmHg) and resulted in small improvements (about 3%) in measures of cognition, 
attention, and vigilance in young students (Bakó-Biró, Clements-Croome et al. 2012). Adults 
working in office environments showed decreased performance using the Strategic Management 
Simulation (SMS) software tool in several of the 9 tests of higher-order decision making with 
PCO2 in the range of 1.1 to 1.9 mmHg (Allen, MacNaughton et al. 2016), (Satish, Mendell et al. 
2012). In contrast, Rodeheffer (Rodeheffer, Chabal et al. 2018) could not replicate the results 
from Satish or Allen at a PCO2 of 1.9 mmHg in submariners using the same SMS software. He 
exposed 36 men: 12 each to PCO2s of 0.4, 1.9, and 11.4 mmHg. After 45 minutes of 
acclimitization to the condition the resting men completed the 9 neurocognitive elements of the 
SMS in 80 minutes. There was no difference in the 9 outcomes between the 3 conditions; the 
submariners did not experience any deficits in decision-making ability. He suggested that prior 
exposure to hypercapnic conditions in submariners may have pre-adapted this group to 
hypercapnia. Allen (Allen, MacNaughton et al. 2018) evaluated flight simulator performance 
during acute mild hypercapnia of 0.5, 1.1, and 1.9 mmHg PCO2 in 30 experienced commercial 
pilots. Federal Aviation Administration Designated Pilot Examiners graded performance on 21 
flight maneuvers during 180 minute sessions where groups of 2 pilots each flew for 90 minutes. 
With 1.9 mmHg PCO2 (2,500 ppm) as reference, the odds of passing a maneuver were 1.52 times 
higher when the pilots were exposed to 1.1 mmHg (1,500 ppm) and 1.69 times greater than when 
exposed to 0.5 mmHg (700 ppm), but this difference was not statistically significant. The 
negative effects of CO2 on flight performance became more pronounced the longer the pilots 
were in the simulator. These results, in part, have motivated the National Research Council to 
investigate standards for flight deck ventilation rates.      
 Others show that mental performance in an acute 80 minute exposure in resting subjects 
did not diminish until a PCO2 of about 34 mmHg was exceeded (Sayers, Smith et al. 1987). 
Vercruyssen has published extensively about acute hypercapnia from 2% to 4% CO2 (PCO2 from 
15.2 to 30.4 mmHg) during physical activity with little change in psychomotor and mental 
performance (Vercruyssen and Kamon 1984), (Vercruyssen, Kamon et al. 2007), (Vercruyssen 
2014). In 1984 he showed no change in cognitive and psychomotor performance with 15.2 
mmHg (2% CO2) combined with 75% V̇O2peak exercise for 40 minutes of a 60 minute CO2 
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exposure. The results were the same if 50% O2 was tested or if 50% O2 plus 2% CO2 was tested. 
He then tested CO2 at 3% and 4% in 50% O2, keeping his methods the same, and again showed 
no impairment in cognition or psychomotor performance (Vercruyssen, Kamon et al. 2007). 
Finally, breathing 4% CO2 (PCO2 of 30.2 mmHg) in 50% O2 for 1 hour in resting subjects did 
increase information processing time (Vercruyssen 2014); however, changes in other sensitive 
metrics would seem to have little relevance to EVA performance. Some subjects did report 
headaches that cleared quickly in fresh air, and were not observed on subsequent test days. 
Sheehy (Sheehy, Kamon et al. 1982) had similar results with 5% CO2 (PCO2 of 38.0 mmHg) 
combined with exercise, but the treadmill exercise was only 10 minutes. He combined 4% or 5% 
CO2 in air or 50% O2 with 10 minutes of exercise at 80% V̇O2max and found no deterioration in 
a multitude of psychomotor and mental performance tests during the 6 minutes of recovery while 
still breathing the test gases. Some subjects did report headaches and lightheadedness that 
cleared with fresh air. A 4% CO2 exposure during bed rest for 2 weeks had no impact on 
psychomotor performance (Storm and Giannetta 1974). Storm in 1974 performed the first study 
combining a PCO2 of 30 mmHg with 2 weeks of bed rest. He provided convincing evidence of 
no detrimental effect on complex tracking performance, eye-hand coordination, or problem 
solving ability either with bed rest, hypercapnia, or the combination of both conditions. Manzey 
(Manzey and Lorenz 1998) concluded that after 26 days of exposure to as much as 1.2% CO2 
(PCO2 of 9.1 mmHg) that 4 males subjectively perceived reductions in alertness and slight 
performance decrements in a tracking task. An unstable tracking task showed a greater root-
mean-square tracking error (see their Figure 2) when compared to baseline values in both the 
0.7% and 1.2% exposures. In contrast to the 0.7% condition, the time course of change under the 
1.2% condition seemed related to the CO2 load and covaried with a loss of subjective alertness. 
Manzey concluded that at least visuomotor performance might be affected by chronic CO2 
concentrations ≤9.1 mmHg. He says that prolonged exposures to CO2 concentrations as high as 
1.2% appear to be tolerable with regard to their behavioral effects.      
Several other investigators also concluded that there was no consistent relationship 
between CO2 exposure and cognition or motor function within an operational EVA PCO2 range 
<20 mmHg (Bloch-Salisbury, Lansing et al. 2000), (Henning, Sauter et al. 1990), (Sheehy, 
Kamon et al. 1982), (Selkirk, Shykoff et al. 2010), (Weybrew 1970). The work by Bloch-
Salisbury is particularly relevant to EVA with resting astronauts exposed to PaCO2 on the order 
of 47 mmHg. Changes in electroencephalogram (EEG) brain waves with hypercapnia were noted 
by Bloch-Salisbury, as expected, since the CNS is the integrator of changes in the body. 
However, the changes in EEG did not affect cognitive function. Thesen (Thesen, Leontiev et al. 
2012) tested in 7 subjects acute, cyclic exposure to 5% CO2 in 21% O2 and air, increasing 
PETCO2 by about 8 mmHg during the cycles. They tested whether mild hypercapnia would 
decrease the magnetoencphalogram response to auditory pattern recognition and visual semantic 
tasks. There were decreases in event-related fields without affecting behavioral performance. 
They advance a homeostatic hypothesis for the observed changes in EEG with hypercapnia 
based on changes in [H+]. Under normal conditions, low cerebral pH would arise when 
bloodflow is unable to compensate for neural activity. The observed cortical depression during 
hypercapnia may reflect a preservation mechanism by which neuronal activity is adjusted to a 
level that can be sustained by available bloodflow. Even though MCA bloodflow is elevated by 
hypercapnia (Halpern, Neufeld et al. 2003), the increase in [H+] from exogenous CO2 appears to 
trigger a generalized depressive effect on cortical activity. The universal nature of the neural 
suppression may explain why, despite its large and widespread effects on neural activity, 
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hypercapnia did not affect performance speed or accuracy on either task, similar to what was 
reported by Bloch-Salisbury.  
EEG also changes as part of hypercapnia associated in those with sleep disorders (Wang, 
Piper et al. 2011, Wang, Piper et al. 2014, Wang, Yee et al. 2015). We do not cover the vast 
literature about linking changes in EEG activity with changes in function. Just a few 
observations about acute hypercapnia. Wang (Wang, Yee et al. 2015) tested 20 subjects during 
acute, 5-minute hypercapnia from rebreathing. The procedure increased mean PCO2 in the 
breathing circuit from 36 mmHg in control air to about 47 mmHg under hypoxic (PO2 = 56 
mmHg) or hyperoxic (PO2 = 150 mmHg) conditions. In both cases there was an increase from 7 
to 10 in the ratio of delta (δ) wave power to alpha (α) wave power (δ/α) from EEG during the 
rebreathing. No cognitive or performance measures were taken over this short interval, just a 
demonstration that hypercapnia but not hypoxia caused EEG slowing, which might indicate a 
depression of cortical neuroelectrical activity. Patients with sleep disorders had PaCO2 near 55 
mmHg, which Wang (Wang, Piper et al. 2014) attributed to daytime drowsiness and sleepiness. 
These patients had slower EEG, as quantified by a higher δ/α ratio. Once nighttime continuous 
positive airway pressure was started, PaCO2 decreased to about 45 mmHg and the δ/α ratio 
decreased to between 5 and 7 and patients reported greater restful sleep. A lower δ/α ratio 
indicates a faster, more activated EEG spectral profile. They conclude that sleep hypercapnia 
resulted in daytime drowsiness secondary to reduced brain neuroelectrical activation and overall 
depression of cortical activity. Halpern (Halpern, Neufeld et al. 2003) also showed a similar 
increase in δ/α ratio during CO2 rebreathing to conclude this cursory discussion. 
The U.S. Navy has extensivly researched the causes and consequences of acute 
hypercapnia in divers, particularly in the performance of CO2 scrubbers and increased breathing 
resistance at depth with exercise. A recent 2015 report by Haran (Haran and Lovelace 2015) and 
a particularly detailed report in 2010 (Selkirk, Shykoff et al. 2010) document minimal changes in 
neurocognitive and postural stability after execise in 12 feet fresh water with CO2 exposure up to 
3% (PCO2 of 28.3 mmHg) sea level equivalent either in air or 1.4 ATM O2. Dives lasted for 3.5 
hours with intervals of 30-minute cycle ergometry, otherwise rest. There were many symptoms 
associated with this testing, including headache, inability to concentrate, and irritability but there 
was little impairment in sensitive neurocognitive tests. From their abstract, “Basic cognitive 
domains of simple reaction time, visual scanning, visuo-spatial processing, and learning were 
unaffected, while fatigue and the higher cognitive functions of short-term memory, long-term 
memory, working memory, math processing, and sustained attention produced perplexing 
results. Most consistent of all differences was a decrease in long-term memory while divers were 
on CO2, a decrease that persisted in Phase 1 even after divers were removed from CO2 and 
returned to O2.” Bacal (Bacal, Beck et al. 2008) provides a table (Table 22.7) that compiles 
assessment of exercise and mental performance as PCO2 increases. It appears that PCO2 <30 
mmHg for durations relevant to EVA do not significantly impact physical and mental 
performance, at least well-learned tasks in a 1G environment.  
Clear vision is required for optimal performance. Hypercapnia could influence the retina 
as well as neurons along the pathway to the visual cortex. Sun (Sun, Sun et al. 1996) and Yang 
(Yang, Sun et al. 1997) exposed 3 subjects each to 2.5% CO2 (PCO2 of 19 mmHg) and measured 
a decreased stereoacuity and increased stereoscopic threshold, respectively. Stereoacuity is the 
reciprocal of stereoscopic threshold, so both investigators were reporting similar results in 
different ways. They concluded that fine detection of the depth of an object and the threshold 
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detection of motion are influenced by as little as 19 mmHg PCO2. Each referenced earlier work 
by Weitzman (Weitzman, Kinney et al. 1969). Weitzman reported in 1 male that repeated 
exposure over 6 days to as much as 3% CO2 impaired scotopic and green color detection 
sensitivity, but several other measures of visual performance were unchanged. Specific research 
is needed to understand the functional significance of changes to cognition and perception in an 
operational EVA and LEA environment. 
James (James, Meyers et al. 2011) and Law (Law, Van Baalen et al. 2014) confronted the 
difficulty in defining unacceptable risk of acute hypercapnia. They could not prospectively 
define an adverse effect of hypercapnia, within the range of CO2 on the ISS. Their work about 
hypercapnia on the ISS has some relevance to EVA since they statistically evaluated acute PCO2 
before private medical conferences that included reports of headache. Both used the prevalence 
of headache as a response variable that could be evaluated. Their analysis concluded that the 
probability of headache is <1% if PCO2 is <2.3–2.5 mmHg, but added that headache on ISS is 
not a serious medical concern. However, a severe headache is debilitating. James used the term 
“subtle adverse effects” several times as something to avoid with acute hypercapnia, but subtle 
and adverse are the antithesis of each other. This is a clear indication that defining unacceptable 
risk in neurocognition, particularly complex decision making, and performance with hypercapnia 
during EVA is an area of new research. Staal (Staal 2004) provides an extensive review of the 
many dimensions of how stressors interact with cognition and human performance.   
During EVA, there has been only one report of a mild headache lasting 15 minutes with 
accompanying photophobia in the literature (Vein, Koppen et al. 2009). This headache was not 
specifically attributed to CO2. Otherwise, there are no known reports of diminished 
neurocognitive performance during EVA exposures during flight and training. On the contrary, 
there are astronaut reports of headaches improving after donning the EMU (Law, Watkins et al. 
2010), (Kelly 2017).  Research is underway to characterize the CO2 exposure levels associated 
with the EMU at various metabolic rates. The expectation is that the levels experienced in the 
EMU at typical metabolic rates between 500 – 1500 BTU/h would be considered acceptable 
because of the lack of symptoms reported during hundreds of flight EVAs and thousands of EVA 
training runs in the Neutral Buoyancy Laboratory. 
 EVA presents a high stress and high risk environment where astronauts are required to 
perform mission critical tasks that require a combination of physical demand and high cognitive 
level.  During EVAs astronauts can experience increasing physical and cognitive fatigue due to 
several factors: suit-fit issues, temperature fluctuations, hypercapnia, and the challenge of the 
EVA task at hand.  As we move from low Earth orbit to exploration class missions EVAs will be 
more physically and mentally demanding since autonomy and novel (untrained) mission 
scenarios is the new paradigm. Performance of a new or off-nominal task during EVA with 
required procedure deviations may be significantly compromised when cognition is impared. 
Accordingly, the ability to predict and then mitigate acute cognitive changes, predict onset of 
cognitive deterioration, and most importantly, understand the impacts of cognitive deterioration 
in specific domains (ie, spatial orientation, abstract reasoning, emotion processing, stability of 
sustained attention, and risk decision making) on EVA task performance is critical. None of this 
critical information is in the literature. 
  
 29 
 
13.0 MITIGATION OF AND RECOVERY FROM HYPERCAPNIA DURING 
EXTRAVEHICULAR ACTIVITY 
Unlike many of the exposures to CO2 described in the literature, the astronaut is the 
specific source of the CO2 that they are exposed to and therefore exerts some control on the 
mitigation of high levels of CO2. In a space suit, metabolically produced CO2 is removed through 
one of several different potential chemical processes in the portable life support systems and then 
circulated back into the space suit through the ventilation loop. Direction of the inlet gas towards 
the face is designed to help wash away expired CO2 and to provide access to air with less CO2. 
No CO2 removal is 100% perfect, and it is expected from past experience (Michel, Sharma et al. 
1969), (Bekdash, Norcross et al. 2017) that somewhere between 0.5-2 mmHg remains in the gas 
supply even after CO2 removal.  
One consistent feature of all studies examining CO2 exposures in space suits is that PICO2 
increases with increased energy expenditure. This is independent of the method used to measure 
CO2 in the suit. This is a logical and consistent finding because a space suit is set to operate at a 
constant flow rate through the ventilation loop. Therefore, assuming a functional space suit, the 
primary reason an astronaut will be exposed to high levels of CO2 is due to metabolic 
production. Therefore, should CO2 symptoms be experienced during any suited activity, the first 
step should be for the astronaut to stop the activity and reduce the metabolic CO2 production. 
Although this topic has not widely been discussed in the literature, we have seen CO2 levels in 
the oronasal area decrease rapidly within 1-2 minutes after test subjects complete high metabolic 
rate test points at 2000-3000 BTU/h and begin resting.  
Even if the PICO2 level can quickly be reduced in the space suit, it has little relevance if 
the time for an astronaut to recover from a high CO2 exposure is excessive. Fortunately, this 
recovery time seems to be fast as well. Reynolds (Reynolds, Milhorn et al. 1972) showed that 
respiratory variables including V̇E, VT, RR, PACO2 and PAO2 all returned to normal within a few 
minutes after 25 minute exposures to PCO2 levels of 22.8, 38, 45.6 and 53.2 mmHg. In another 
study, PACO2 and pH returned to baseline levels within 5 minutes after a 3 hour exposure, which 
ramped PICO2 from 7 to 42 mmHg by 7 mmHg increments every 30 minutes (Forster, Klein et 
al. 1982). Recovery of pH and PaCO2 occurred within the 7 minute test period after exposure to 
PCO2 levels 7.6 and 15.2 mmHg (Ellingsen, Sydnes et al. 1987). It seems that recovery from 
hypercapnia is rapid; however, in a space suit environment, one may rapidly recover to a lower 
PICO2 that is still too high. 
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14.0 EXTRAVEHICULAR ACTIVITY-SPECIFIC INITIAL CONCLUSIONS 
The purpose of this literature review was to provide relevant background information to 
assist in the evidence-based recommendation of an inspired CO2 requirement for the xEMU 
space suit. The xEMU is expected to be used for a maximum of 8 hours EVA preceded by up to 
4 hours of in-suit prebreathe. With this application in mind, the following conclusions are 
provided with respect to healthy astronaut populations, based on review of the literature 
described herein.  
 
1. A current industry standard [NIOSH/OSHA/ACGIH] of 5,000 ppm, 0.5% dry-gas CO2 (PCO2 
of 3.8 mmHg with PICO2 of 3.5 mmHg for time weighed average 8-10 h/day, 40 h/wk is 
documented (https://www.osha.gov/dsg/annotated-pels/tablez-1.html). The standard applies to 
the general, adult working population with a range of health issues associated with an adult 
working population.  Therefore, the standard applies to an office or school environment, to operators 
of vehicles, to workers on the factory floor, etc. Short-term exposure to 30,000 ppm (3%) for 
approximately 15 minutes is also permitted. With this brief background about general-population 
CO2 limits, we now summarize EVA-specific conclusions based on our literature review. 
 
2. Otherwise healthy adults can accommodate an acute PCO2 of 15.2 mmHg at 760 mmHg ambient 
pressure (2% CO2 sea level equivalent, PICO2 = 14.2 mmHg) at rest and during exercise anticipated 
during EVA and LEA operations. This level is associated with acceptable, reversible physiologic 
alterations like changes in VT, PaCO2, pH, etc. Astronauts sensitive to CO2 may express symptoms like 
dyspnea and headache, but these will not be performance limiting. There are no obvious neurocognitive 
or EVA performance issues expected. While some may not consider this conservative enough for the 
EVA application, it could be used as a do not exceed target. 
 
3. Exposures to a PICO2 ≤ 7.1 mmHg would be acceptable for acute exposure based on previous 
review papers and a long history of spaceflight operations. Literature data indicates no expectation of 
neurocognitive or physiologic health or performance issues at these levels for this population.  
 
4. Exposures to a PCO2 of 7.6 to 11 mmHg are still widely considered acceptable [relevant 
examples include (Bacal, Beck et al. 2008), (Rodeheffer, Chabal et al. 2018), (Clark, Sinclair et 
al. 1980) for expected EVA durations, based on small physiologic changes and acceptable 
neurocognitive performance. Symptoms reported at these PCO2 levels in the literature are limited 
to small, measurable physiologic responses such as increased V̇E and decreased pH, but are well 
within acceptable limits. 
 
5. Careful review of the EMU CO2 washout test results will help identify the targeted nominal 
EVA PICO2 levels that have been tolerated without any CO2 related symptoms reported. These 
values should weigh heavily on the exposure guidelines. 
 
6. Physiologic changes associated with acute exposures to elevated CO2 levels return to normal 
within minutes after return to normal CO2 levels. 
 
7. PICO2 is a practical measure of hypercapnic dose that accounts for water vapor dilution at any 
PB: PICO2 = (PB–47) × FICO2, where PB is ambient pressure as mmHg, 47 is mmHg water vapor 
pressure at body temperature of 37°C, and FICO2 is dry-gas decimal fraction of CO2 in breathing 
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atmosphere. For instance, a PICO2 of 14.2 mmHg would result from an inlet PCO2 from the 
scubber for a specific PB that establishes a constant PICO2 of 14.2 mmHg (see table examples). 
 
Table 5.  Examples of IsoPICO2 Conditions 
PB 
(psia)       (mmHg) 
FICO2              PCO2 
                     (mmHg) 
PICO2 
(mmHg) 
20.0            1034 0.0144             14.88 14.2 
14.7             760 0.0200             15.20 14.2 
8.0              413 0.0388             16.02 14.2 
4.3              222 0.0811             18.00 14.2 
 
8. Otherwise healthy astronauts adapted to µG have no significant physiologic impediments to 
pulmonary gas exchange that would make them more hypercapnic than expected during EVA if 
CO2 is breathed. 
 
9. There were no data on acute, repetitive hypercapnic exposure to understand changes in 
physiology during cyclical response and recovery. 
 
10. There were no data on acute, repetitive hypercapnic exposure where recovery was in an 
environment of elevated PCO2. Therefore, we lack an understanding of physiologic changes 
during cyclical response and recovery where recovery is in an environment of elevated PCO2. 
 
11. There is no absolute “Gold Standard” for an acceptable acute hypercapnic limit, just a 
gradual decrease in performance as PICO2 increases. 
 
12. Otherwise healthy astronauts will exhibit wide variability in responses to acute hypercapnia 
while at rest and during exercise. 
 
13. No prospective reject criteria currently exits to define unacceptable physiologic, 
neurocognitive, or performance responses to acute hypercapnia at rest and during exercise. The 
reality is that an acceptable limit is occupation, situation (learned or novel tasks), and person-
specific. Until these criteria are defined, a consensus of expert opinion is the only approach to 
define an acute hypercapnic limit for a heterogenous population of EVA astronauts. 
 
14. There will always be some uncertainty about application of CO2 results from normobaric  
exposure in 1G to hypobaric exposure in µG. Both the physical environment (gas density, total 
pressure, PIO2, method of exercise, etc.) and the physiology (adaptation to µG, including 
hypercapnia) are differently adapted. But these differences are considered minimal if PaCO2, 
then PACO2, and then PICO2, in that order, are the same between ground testing and EVA. If 
hypercapnic dose is equivalent between ground testing and EVA, then we hypothesize identical 
physiologic, neurocognitive, and functional performance responses. Operational EVA experience 
to date (landing on the moon and building a space station) is evidence that current space suit CO2 
limits established on Earth do apply in µG. In other words, there appears to be no single change 
or combination of changes associated with “space adaptation syndrome” that invalidates EVA 
CO2 limits established in 1G for application in µG.  
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APPENDIX – LITERATURE EXCERPTS ABOUT ACUTE CARBON DIOXIDE 
EXPOSURE 
A scheme to categorize literature reports is necessary to facilitate an orderly collection and 
analysis of those reports. We divided reports about hypercapnic exposure as follows:   
Hypercapnia; PCO2 >0.23 mmHg (fresh air @ 760 mmHg) 
Normobaric; PB between 740–770 mmHg 
Hypobaric; PB <740 mmHg 
Hyperbaric; PB >770 mmHg 
Normoxic; PIO2 between 145–152 mmHg 
Hypoxic; PIO2 <145 mmHg 
Hyperoxic; PIO2 >152 mmHg 
Normal Gravity; Earth-normal 1G 
Abnormal Gravity; <1G (state of free-fall or planetary surface) or bed rest analog. 
A-1 Hypercapnia in normobaric normoxia with rest and exercise in 1G. 
(Alexander, West et al. 1955) 
Provided early comprehensive respiratory and arterial blood gas data from 12 resting subjects 
after about 30 minutes of breathing air (control), 3%, and 5% CO2 in air. Showed that 
physiologic dead space volume (VD) increased as CO2 concentration in air increased. He 
concluded that chronic hypercapnia results in a diminished sensitivity to inhaled CO2, which is 
associated with a rise in both PaCO2 and [H+]a.   
(Clark, Sinclair et al. 1980) 
Evaluated a range of PICO2 from 0 to 40 mmHg over a range of V̇O2max from resting (7% V̇O2max) to extreme exercise (80% V̇O2max, about 3.6 L(STPD) O2/min) in 9 young men using 
treadmill at 10% grade with 6 minutes at 1.8, 3.4, 4.8, and 6 mph. No difference (change) in V̇O2 
or V̇CO2 with increasing hypercapnia. RER increased as V̇O2 increased with no modification 
(decrease) due to hypercapnia, as seen by others. Mean blood lactate increased as V̇O2 increased 
and was not modified (decreased) with hypercapnia, as seen by others. For example, at V̇CO2 of 
3.0 L/min, blood lactate was about 5 mM/L over the range of PaCO2 from 35 to 60 mmHg. The 
following data are means from 9 men. 
Table A1. RER (?̇?𝐕CO2/?̇?𝐕O2) 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇C2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 0.80 0.80 0.89 0.96 1.03 
10 0.78 0.81 0.91 0.98 1.04 
20 0.78 0.81 0.94 1.01 1.06 
30 0.86 0.86 0.95 1.06 1.07 
40 0.75 0.87 0.98 1.02 1.10 
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𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓 𝐓𝐓𝐀𝐀. ?̇?𝐕E L(BTPS)/min  
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 10.09 27.3 46.5 88.3 124.1 
10 12.5 34.6 59.2 109.8 141.0 
20 17.2 45.0 73.6 122.9 153.2 
30 27.3 65.8 93.0 142.1 161.0 
40 46.2 89.4 115.7 151.3 169.0 
TABLE A3. VT L(BTPS) 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 0.712 1.169 1.603 2.266 2.502 
10 0.836 1.405 1.860 2.601 2.760 
20 0.923 1.734 2.265 2.786 3.018 
30 1.361 2.254 2.672 3.083 3.090 
40 1.817 2.713 2.901 3.198 3.274 
 
  
Figure A-1   Figure A-2 
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TABLE A4.  PaCO2 (mmHg) from arterial blood-gas 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 39.7 41.5 41.4 38.1 34.8 
10 40.7 42.9 43.3 41.5 40.1 
20 41.7 44.6 46.5 47.4 47.2 
30 44.9 48.8 51.8 54.8 55.5 
40 48.9 54.1 57.3 62.1 64.2 
𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓  𝐓𝐓𝐀𝐀.  𝐕𝐕̇ A L(BTPS)/min (computed) 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 5.41 18.07 33.65 66.59 93.01 
10 6.92 23.28 42.67 83.13 108.42 
20 9.61 31.44 55.07 94.42 121.72 
30 16.47 45.47 68.93 111.27 131.23 
40 25.59 59.77 85.47 119.19 140.11 
TABLE A6.  VD L(BTPS) (computed) 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 0.325 0.392 0.442 0.553 0.622 
10 0.371 0.458 0.518 0.631 0.636 
20 0.339 0.524 0.568 0.644 0.617 
30 0.543 0.700 0.695 0.662 0.562 
40 0.814 0.880 0.742 0.676 0.562 
 
 35 
 
  
Figure A-3 Plot of Table A-6 data.  Figure A-4 Plot of Table A-6 data.  
 
Table A7.  VD/VT L(BTPS) (ratio by Conkin using authors’ inputs) 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 0.456 0.335 0.275 0.244 0.248 
10 0.443 0.326 0.278 0.242 0.230 
20 0.367 0.302 0.250 0.231 0.204 
30 0.399 0.310 0.260 0.214 0.182 
40 0.448 0.324 0.255 0.211 0.171 
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Figure A-5 Plot of Table A-7 data. Figure A-6 Plot of Table A-7 data. 
 
𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓𝐓 𝐓𝐓𝐀𝐀.  𝐕𝐕̇ CO2 L(BTPS)/min 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 0.243 0.849 1.576 2.854 3.608 
10 0.233 0.862 1.600 2.937 3.649 
20 0.235 0.870 1.657 2.958 3.785 
30 0.264 0.936 1.679 3.145 3.822 
40 0.263 0.982 1.739 3.062 3.961 
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Figure A-7 Figure A-8 
 
Table A9.  Lactate (mEq/L) 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 0.93 0.88 1.71 4.78 9.28 
10 1.11 1.09 1.84 5.56 9.67 
20 0.85 0.79 1.49 4.25 8.48 
30 0.96 0.90 1.53 4.80 9.56 
40 0.91 0.95 1.70 5.07 9.47 
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Figure A-9 
Table A10.  HCO3- (mEq/L) 
PICO2 
mmHg 
0.30 V̇O2 
L(STPD)/min 
1.08 V̇O2 
L(STPD)/min 
1.78 V̇O2 
L(STPD)/min 
3.00 V̇O2 
L(STPD)/min 
3.57 V̇O2 
L(STPD)/min 
0 24.2 24.7 24.3 21.3 17.3 
10 24.4 24.9 24.4 21.8 18.1 
20 24.6 25.2 24.8 22.9 19.4 
30 25.0 25.7 25.4 23.2 19.9 
40 25.3 26.0 25.4 23.3 20.2 
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Table A11.  Compilation of Results from Clark Relevant to EVA 
 
PICO2 
(mmHg) 
 V̇O2 
L(STPD)/min 
 
PaCO2 
(mmHg) 
 
Lactate 
(mEq/L) 
 
HCO3- 
(mEq/L) 
 
[H+] 
(nM/L) 
pH 
-log10 
[H+] 
V̇E 
L(BTPS)/min 
 
RER 
0 0.3 39.7 0.93 24.2 40.0 7.398 10.09 0.80 
10 0.3 40.7 1.11 24.4 41.0 7.387 12.5 0.78 
20 0.3 41.7 0.85 24.6 41.5 7.381 17.2 0.78 
         
0 1.08 41.5 0.88 24.7 41.0 7.387 27.3 0.80 
10 1.08 42.9 1.09 24.9 42.0 7.376 34.6 0.81 
20 1.08 44.6 0.79 25.2 43.0 7.366 45.0 0.81 
         
0 1.78 42.4 1.71 24.3 42.0 7.376 46.5 0.89 
10 1.78 43.3 1.84 24.4 43.0 7.366 59.2 0.91 
20 1.78 46.5 1.49 24.8 45.0 7.346 73.6 0.94 
         
0 3.0 38.1 4.78 21.3 43.0 7.366 88.3 0.96 
10 3.0 41.5 5.56 21.8 45.0 7.346 109.8 0.98 
20 3.0 47.4 4.25 22.9 49.0 7.310 122.9 1.01 
Note: nM/L = 10-9 Eq/L, so 40 nM/L = 40 × 10-9 Eq/L = -log10 [40 × 10-9 ] = 7.4 
(Jacobi, Iyawe et al. 1987) 
Time to reach steady-state during hypercapnic exercise is not universally accepted. As a result, 
conclusions about respiratory control of V̇E response to hypercapnic exercise are sensitive to how 
steady-state is defined. 
(Graham, Wilson et al. 1982) 
Hypercapnia with 0%, 2%, 4%, and 6% CO2 in air at 55% and 65% V̇O2max exercise during 30 
minutes of steady-state bicycle ergometry increased PCO2 in arterialized venous blood and 
decreased pH. No difference (change) in V̇O2 with increasing hypercapnia with exercise but a 
decrease in V̇CO2 with increasing hypercapnia with exercise. RER was lower at 55% and 65% V̇O2max with hypercapnia. Mean blood lactate under hypercapnic exercise was reduced from 
3.88 mM/L to 2.22 mM/L while breathing 6% CO2 for 30 minutes at 65% V̇O2max. RER results 
suggest that with hypercapnia and the subsequent decrease in pH that respiratory acidosis and 
metabolic acidosis during hypercapnic exercise inhibited carbohydrate metabolism in favor of 
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lipid metabolism. Like Menn et al., 1970, V̇O2 for a given V̇O2max is the same regardless of 
hypercapnia, but V̇CO2 for a given V̇O2max is decreased in response to hypercapnia. Menn 
attributes results to CO2 retention while Graham says CO2 retention in minimal and suggests a 
shift from carbohydrate to lipid metabolism in response to decreased pH secondary to 
hypercapnia.    
Table A12.  Metabolic Response to Hypercapnic Exercise 
 
 
CO2 
% 
 
 
PICO2* 
(mmHg) 
V̇O2 
55% V̇O2 
max 
(STPD) 
V̇CO2 
55% V̇O2 
max 
(STPD) 
RER 
55% V̇O2 
max 
V̇O2 
65% V̇O2 
max 
(STPD) 
V̇CO2 
65% V̇O2 
max 
(STPD) 
RER 
65% V̇O2 
max 
0 0 1.85 1.78 0.96 2.37 2.24 0.95 
2 14 2.03 1.83 0.89 2.37 2.20 0.92 
4 28 1.94 1.70 0.86 2.46 2.16 0.88 
6 43 2.09 1.71 0.88 2.39 2.03 0.85 
Mean values. 
*calculated based on PB = 760 mmHg 
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Figure A-10 Note: Means from 6 men with 30 minutes of exercise at 55% (I) and 65% (II) 
?̇?𝐕O2max. 
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Figure A-11 Note: Mean results from 65% ?̇?𝐕O2max exercise over 30 minutes. Data for the 
no CO2 condition is from arterialized venous PCO2 near 34 mmHg (RER ≈ 
0.95) and increases to the 6% CO2 condition for PCO2 near 52 mmHg (RER ≈ 
0.85). 
  
(Menn, Sinclair et al. 1970) 
Acute exercise response in 8 men during steady-state bicycle ergometry for 30 minutes to 0, 8, 
15, 21, and 30 mmHg PICO2 in air was not difficult at <15 mmHg. RER was similar (about 0.88) 
with 1/2 V̇O2max over the hypercapnic range but decreased when at 2/3 V̇O2max. There was CO2 
retention during high exercise combined with hypercapnia. There was no difference (change) in V̇O2 during exercise with hypercapnia. 
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Table A13.  Data Showing Hypercapnic CO2 Retention 
PICO2 
mmHg 
V̇E rest 
L/min 
(BTPS) 
PaCO2 
rest 
mmHg 
V̇E 2/3 V̇O2 
max 
(BTPS) 
PaCO2 
2/3 V̇O2 
max 
mmHg 
V̇O2 
1/2 V̇O2 
max 
(STPD) 
V̇CO2 
1/2 V̇O2 
max 
(STPD) 
RER 
1/2 V̇O2 
max 
V̇O2 
2/3 V̇O2 
max 
(STPD) 
V̇CO2 
2/3 V̇O2 
max 
(STPD) 
RER 
2/3 V̇O2 
max 
0 9.9 40.0 75.5 38.9 2.018 1.764 0.88 2.566 2.430 0.95 
8 11.4 40.3 78.6 40.8 1.967 1.720 0.87 2.476 2.276 0.92 
15 13.7 43.3 80.6 47.8 2.106 1.946 0.92 2.418 2.057 0.85 
21 12.8 42.9 86.9 51.5 1.925 1.654 0.86 2.587 2.119 0.82 
30 24.2 46.0 103.4 56.6 no data no data no data 2.557 1.841 0.72 
Note: Mean values. 
 
Table A14.  Rest Data – Evaluation of Wasted Ventilation with Resting Hypercapnia 
PICO2 
mmHg 
VT 
rest 
L(BTPS) 
PaCO2  
rest  
mmHg 
V̇E  
rest 
L/min 
(BTPS) 
V̇CO2 
rest  
L/min 
(STPD) 
V̇O2 
rest 
L/min 
(STPD) 
RER  
rest 
V̇A   
rest 
L/min 
(BTPS) 
VD 
rest 
L 
(BTPS) 
VD/VT 
rest 
0 0.62 40.0 9.9 ---- ---- ---- ---- ---- ---- 
8 0.64 40.3 11.4 ---- ---- ---- ---- ---- ---- 
15 0.78 43.3 13.7 ---- ---- ---- ---- ---- ---- 
21 0.81 42.9 12.8 ---- ---- ---- ---- ---- ---- 
30 1.26 46.0 24.2 ---- ---- ---- ---- ---- ---- 
Note: Mean values. 
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Table A15.  ½ ?̇?𝐕O2max Exercise Data-Evaluation of Wasted Ventilation with Exercise & 
Hypercapnia 
PICO2 
mmHg 
VT 
½V̇O2 
max 
L(BTPS) 
PaCO2  
½V̇O2 
max 
mmHg 
V̇E  
½V̇O2 
max 
L/min 
(BTPS) 
V̇CO2 
½V̇O2 
max 
L/min 
(STPD) 
V̇O2  
½V̇O2 
max 
L/min 
(STPD) 
RER  
½V̇O2 
max 
V̇A   
½V̇O2 
max 
L/min 
(BTPS) 
VD  
½V̇O2 
max 
L 
(BTPS) 
VD/VT  
½V̇O2 
max 
0 2.04 ---- 57.1 1.764 2.018 0.88 ---- ---- ---- 
8 1.81 ---- 59.0 1.720 1.967 0.87 ---- ---- ---- 
15 2.06 ---- 67.4 1.946 2.106 0.92 ---- ---- ---- 
21 2.32 ---- 72.3 1.654 1.925 0.86 ---- ---- ---- 
30 ---- ---- ---- ---- ---- ---- ---- ---- ---- 
Note: Mean values. 
Table A16.  2/3 ?̇?𝐕O2max Exercise Data-Evaluation of Wasted Ventilation with Exercise & 
Hypercapnia 
PICO2 
mmHg 
VT  
2/3V̇O2 
max 
L(BTPS) 
PaCO2  
2/3V̇O2 
max 
mmHg 
V̇E  
2/3V̇O2 
max 
L/min 
(BTPS) 
V̇CO2 
2/3V̇O2 
max 
L/min 
(STPD) 
V̇O2 
2/3V̇O2 
max 
L/min 
(STPD) 
RER  
2/3V̇O2 
max 
V̇A   
2/3V̇O2 
max 
L/min 
(BTPS) 
VD  
2/3V̇O2 
max 
L 
(BTPS) 
VD/VT  
2/3V̇O2 
max 
0 2.29 38.9 75.5 2.430 2.566 0.95 54.0 0.65 0.284 
8 2.23 40.8 78.6 2.276 2.476 0.92 59.9 0.54 0.242 
15 2.29 47.8 80.6 2.057 2.418 0.85 54.0 0.75 0.327 
21 2.52 51.5 86.9 2.119 2.587 0.82 60.0 0.78 0.309 
30 2.69 56.6 103.4 1.841 2.557 0.72 60.0 1.13 0.420 
Note: Mean values. 
Decrease in wasted ventilation during exercise without hypercapnia based on Figure 11-5 from 
Murray (Murray 1986), and analysis of literature data with equations that relate respiratory 
volumes and gas partial pressures. 
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Figure A-12  
 PaCO2 = (V̇CO2/V̇A) × 863 + PICO2 
 V̇A = V̇E × [ 1 – VD/VT] 
 VD/VT = (PaCO2 – PETCO2)/PaCO2 
 VD, mL(BTPS) = VT × [(PaCO2 – PETCO2)/(PaCO2 – PICO2)] – VDvalve (dead space of the breathing valve) 
(Murray and Nadel 1988) 
 VD/VT = [(PaCO2 – PETCO2)/(PaCO2 – PICO2)] - VDvalve/VT - VDvalve (Murray and Nadel 1988) 
 V̇A = 0.863 × V̇CO2/PaCO2 
 VD/VT = (V̇E – V̇A)/ V̇E 
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(Sinclair, Clark et al. 1971) 
States that healthy men at rest can tolerate acute and chronic PCO2 up to 30 mmHg, but 
questions how the contribution of exercise would modify this statement. Four males performed 
low, moderate, and heavy bicycle exercise on different occasions for 45 minutes while supine. 
Exercise was during a 1-hour acute exposure to 21 mmHg PCO2 or later after 15–20 days of 
chronic exposure to 21 mmHg PCO2. In the 3 figures that follow, measurements were taken 
between the 12th and 15th minute of low, moderate, and heavy exercise. It was not clear why the 
exercise then continued for 45 minutes. Arterial blood samples were collected.   
 
Figure A-13  shows that the increase in ?̇?𝐕E with increase in HR was not different between 
the acute and chronic exposure to PCO2 of 21 mmHg, but was higher than for 
exercise with air. There is a positive synergy between metabolic and 
respiratory acidosis, at least with PCO2 of 21 mmHg. 
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Figure A-14  This figure shows that for the same HR the ?̇?𝐕O2 is no different between the 3 
conditions (authors statement); however, the elimination of CO2 for the same 
HR at moderate to heavy exercise falls significantly below the line for 
exercise with air. Mean O2 consumption with heavy exercise was 2.41 L(STPD) 
O2/min. He concludes that CO2 retention occurred during exercise in 
hypercapnia that could not be explained by a decrease in metabolism, ie, a 
decrease in ?̇?𝐕O2. 
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Figure A-15 shows PaCO2 decreasing with exercise intensity in air; an efficient ventilation 
is removing CO2 from metabolism. However, PaCO2 further increases from 
the higher baseline values for both the acute and chronic hypercapnia but does 
return to baseline values during heavy exercise. The difference between 
PaCO2 for hypercapnic exercise and exercise with air in panel 3b reflects the 
combined transport of CO2 in arterial blood. The difference between chronic 
and acute exercise hypercapnia was statistically significant. 
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Figure A-16  Figure 4 (above) shows the decrease in pH with hypercapnic exercise was 
similar to exercise with air during moderate and heavy exercise. The 
metabolic acidosis component of the pH change in panel 4b was greater 
during exercise while breathing air and smaller in acute hypercapnia. It is not 
clear how the data in panel 4b were computed.  
(Ellingsen, Sydnes et al. 1987) 
Acute, resting exposures to 1% and 2% CO2 resulted in a small increase in PaCO2 and small 
decrease in arterial blood pH. Increase in V̇E only partially attenuated the increase in PaCO2 which 
is evidence against isocapnic hyperpnea during inhalation of low CO2. 1 kPa = 7.5 mmHg. 
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Figure A-17 
 
(Sayers, Smith et al. 1987) 
For acute, resting exposures of 20 minutes there were no changes in mental performance 
measured in various ways when PETCO2 was less than 51 mmHg (about 5.5% CO2). The author 
concludes a hypercapnic threshold below which mental performance is not affected given the 
acute condition of his test. Longer 80 minute exposures to 6.5% CO2 did alter mood assessment: 
there was increased irritability and discomfort but alertness was unchanged. It took longer to 
complete subtraction and logic problems with PETCO2 of about 55 mmHg. 
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Figure A-18 
(Forster, Klein et al. 1982) 
Some investigators have found hypernea associated without a measurable change in PACO2 and 
suspect chemoreceptors in the lung, independent of the known peripheral or central sensors. 
Ventilation sensitivity (reactivity) is measured as the ratio of ∆V̇E to ∆PACO2, or ∆V̇E/∆PaCO2.  
The point of the study was to determine if this ratio was different under low levels of PICO2 (0.4–
21 mmHg) versus higher levels (28–42 mmHg). ∆V̇E/∆PaCO2 response is less at low PaCO2 and 
greater at higher PaCO2, so they conclude no evidence for additional CO2 sensing in the lungs. 
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Figure A-19 
Notice that PaCO2 is stable as PICO2 increases to 14 mmHg but pH falls over this interval.  
 
Figure A-20 Rest Data – Evaluation of Wasted Ventilation with Resting Hypercapnia 
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Table A17.  Evaluation of Wasted Ventilation with Resting Hypercapnia 
VA rest  
L/min (BTPS) 
PaCO2 rest  
mmHg 
V̇E rest 
L/min (BTPS) 
VD/VT 
rest 
3.0 40.0 4.8 0.37 
6.0 42.0 11.0 0.45 
10.0 44.0 17.5 0.43 
14.0 48.0 25.0 0.44 
 Note: Mean values taken from curves on Figure 3 (above). 
  V̇A = V̇E × [ 1 – VD/VT], or VD/VT = (V̇E – V̇A)/ V̇E 
 
 
Figure A-21 
Notice there is less responsiveness in all responses when with a given ∆PaCO2 when PaCO2 is 
low and with a given ∆pH when pH is in the near normal range, the slopes are smaller on the left 
of the curves compared to the right of the curves.   
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(Gill, Natoli et al. 2014) 
The issue was if hyperoxia exacerbated response to hypercapnia – it did not. Serious symptoms 
of hypercapnia occurred only during normoxia. Serious symptoms with hyperoxic hypercapnia 
were absent because of decreased PETCO2 consequent to increased ventilation. For hyperoxic 
gases, PETCO2 was consistently less than for normoxic gases. A limitation of the study is that 
they did not control for the increase in PN2 (N2 narcosis) while at 6 ATA. 
 
Figure A-22 
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Figure A-23 
 
(Henning, Sauter et al. 1990) 
Acute, resting, normoxic air (21%) with 6% CO2 – balance N2 or 94% O2 with 6% CO2 was 
compared in a cross-over design. Mean PETCO2 was statistically larger for normoxic (49.9 
mmHg) compared to hyperoxic (48.1 mmHg). No significant difference in decrements of several 
measures of performance was assessed by paired comparisons of normoxic versus hyperoxic 
hypercapnia; both conditions showed equal decrements. N2 narcosis was not a confounder in this 
experiment because both conditions were normobaric. 
(Fan and Kayser 2013) 
Increased FICO2 elevated cerebral blood flow during incremental exercise in normoxia, an issue 
for EVA, but did not during hypoxia, not an issue for EVA. Neither in normoxic or hypoxic 
exercise did hypercapnia (PETCO2 held ≈ 45 mmHg) change the increase in V̇O2 or V̇CO2.  
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Figure A-24 
 
(Poon and Greene 1985) 
Exercise up to V̇CO2 of 1.5 L(BTPS)/min with controlled (clamped) hypercapnia from a PaCO2 
between 46–54 mmHg) increases the slope of V̇E versus V̇CO2 and increases the intercept. This is 
an important observation. However, PaCO2 during EVA exercise would not be artificially 
stabilized (clamped). 
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Figure A-25 
 
Figure A-26 
 
 58 
 
 (Satish, Mendell et al. 2012) 
Applied computer-based Strategic Management Simulation software to assess complex cognitive 
function (decision-making) during three acute 2.5-hour sessions with 600 ppm (0.45 mmHg), 
1,000 ppm (0.76 mmHg), and 2,500 ppm (1.9 mmHg) CO2 with ppm concentrations converted to 
PCO2 as mmHg for sea level pressure.  
  
Figure A-27 
10,000 ppm = 1.0% = 7.6 mmHg at sea level.  
2,500 ppm = 0.25% = 1.9 mmHg at sea level.  
 
(Allen, MacNaughton et al. 2016) 
Applied computer-based Strategic Management Simulation software to assess complex cognitive 
function (decision-making) during 6 full work days (9 AM–5 PM) in an environmentally 
controlled office space with CO2 concentrations per subject show in their Figure 2 (below).  
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Figure A-28  Note: Green condition indicates low concentrations of volatile organic 
compounds in breathing gas: 10,000 ppm = 1.0% = 7.6 mmHg at sea level, 
1,500 ppm = 0.15% = 1.1 mmHg at sea level.  
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(Allen, MacNaughton et al. 2018) 
They used a flight simulator to assess commercial pilot performance during 21 maneuvers in 90 
minutes with 30 pilots exposed to 0.5, 1.1, and 1.9 mmHg PCO2. Groups of 2 pilots were 
evaluated by FAA Designated Pilot Examiners where each pilot flew the simulator for 90 
minutes during a 180 minute session. With 1.9 mmHg PCO2 as reference, they showed a greater 
passing scores during simulations with 0.5 and 1.1 mmHg PCO2. Their Figure 2 shows a reduced 
passing rate with increasing hypercapnia to about 1.9 mmHg PCO2, particularly with difficult 
flight maneuvers.  
 
 
Figure A-29 
(Rodeheffer, Chabal et al. 2018) 
Applied computer-based Strategic Management Simulation software to assess complex cognitive 
function (decision-making) during three acute 80 minute sessions with 600 ppm (0.45 mmHg), 
2,500 ppm (1.9 mmHg), and 15,000 ppm (11.4 mmHg) CO2 with ppm concentrations converted 
to PCO2 as mmHg for sea level pressure. 12 resting submariners (mean age 30 years) 
participated in each condition. After 45 minutes of acclimatization to the condition, the resting 
subjects completed over 80 minutes the 9 tests in the Strategic Management Simulation software. 
No difference between conditions was found for any of the 9 tests. 
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Figure A-30 
(Bakó-Biró, Clements-Croome et al. 2012) 
Increasing the ventilation in school class rooms decreased PCO2 from about 1.1 mmHg to 0.34 
mmHg (fresh air is 0.23 mmHg) and resulted in small improvements, about 3%, in measures of 
cognition, attention, and vigilance in young students. 
 
 
Figure A-31 
(Frey, Sulzman et al. 1998) 
Joint NASA-ESA-DARA study on chronic 3-week exposure with 4 men to 0.7% and then again 
to 1.2% CO2 (PCO2 of 5.3 mmHg and 9.1 mmHg, respectively). The general conclusion was that 
no serious medical concerns emerged with PCO2 <9 mmHg (1.2%) for exposures lasting about 3 
weeks, based on research in 1G.   
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(Sliwka, Krasney et al. 1998) 
Joint NASA-ESA-DARA study on chronic 3-week exposure with 4 men to 0.7% and then again 
to 1.2% CO2 (PCO2 of 5.3 mmHg and 9.1 mmHg, respectively). Sliwka insonated the middle 
cerebral arteries of 4 males exposed to 23 days of 0.7% CO2 and another 23 days of 1.2% CO2. 
CBF was elevated by 35% during the first 1–3 days of both exposures but then returned to pre-
test levels. Despite similar CBF responses, headache was only reported during the initial phase of 
exposure to 1.2% CO2. They conclude that the time-dependent change in CO2 vascular reactivity 
might be due either to retention of HCO3- in brain extracellular fluid or to progressive increases 
in ventilation, or both. Cerebral vascular autoregulation was preserved during chronic exposures 
to low-level CO2. The attached figure shows the transient increase in CBF over each CO2 
exposure. 
 
 
Figure A-32 
(Manzey and Lorenz 1998) 
Joint NASA-ESA-DARA study on chronic 3-week exposure with 4 men to 0.7% and then again 
to 1.2% CO2 (PCO2 of 5.3 mmHg and 9.1 mmHg, respectively). Four other subjects served as 
controls for the 0.7% exposure, identified as filled circles in attached figures. All performed a 
sequential series of cognitive, visuomotor, and time-sharing performance tasks 7 days before, 26 
days during mild hypercapnia, and 3 days of recovery. An unstable tracking task showed a 
greater root-mean-square tracking error (see Figure 2) when compared to baseline values in both 
the 0.7% and 1.2% exposures. In contrast to the 0.7% condition, the time course of change under 
the 1.2% condition seemed related to the CO2 load and covaried with a loss of subjective 
alertness. The authors concluded that at least visuomotor performance might be affected by 
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chronic CO2 concentrations ≤9.1 mmHg. Figures 1 and 2 below indicate no operationally 
significant performance deficits, certainly none that would impact acute, repetitive EVA 
exposures. 
 
 
Figure A-33 
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Figure A-34 
     
(Weybrew 1970) 
N = 1, 6 days with 3% CO2 resulted in no significant changes in vigilance, coordination, or simple 
problem solving ability. 
(Reynolds, Milhorn et al. 1972) 
Acute resting 25 minute exposure. Conclusion: Breathing 3% CO2 (PCO2 = 23 mmHg, PICO2 = 
21 mmHg) has an effect on ventilatory response.   
Table A18.  Resting Ventilatory Response to Hypercapnia 
CO2 
% 
V̇E            just air 
L(BTPS)/min 
PACO2       just air 
mmHg 
PAO2       just air 
mmHg 
3 11              8 45         42 120          95 
5 15 48 130 
6 25 49 130 
7 40 55 140 
                Note: Data estimated from Figures 3-6.  
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Figure A-35 
Note: Acute 3% CO2 exposure while resting 
at sea level. 
Figure A-36 
Note: Acute 3%, 5%, 6%, and 7% CO2 
exposure while resting at sea level. 
 
(Balanos, Talbot et al. 2003) 
Vascular tone in the pulmonary circulation is substantial and can be increased with hypercapnia 
and decreased with hypocapnia. Variations in CO2 and O2 play a role in matching ventilation to 
perfusion. 
(Fothergill, Hedges et al. 1991) 
See summary under #7. 
(Ainslie and Duffin 2009) 
Extensive review about the control of cerebral blood flow, particularly the role of PaCO2. 
Cerebrovascular reactivity and ventilatory response to PaCO2 are tightly linked since the aim is 
to maintain stable CSF [H+, pH]. The review covers cerebrovascular CO2 reactivity during sleep 
and exercise, as measured by MCA blood flow. 
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Figure A-37 
(Storm and Giannetta 1974) 
See summary under #2. 
(Dahan, DeGoede et al. 1990) 
Complex experiment with 9 resting males breathing CO2 to set PETCO2 between 45.0 and 52.5 
mmHg during 3 O2 conditions: PETO2 at 750 mmHg (hyperoxic), 109 mmHg (normoxic, and 75 
mmHg (hypoxic). They were looking for the roles of peripheral and central chemoreceptors in the 
ventilatory response to CO2 under hyperoxic, normoxic, and hypoxic conditions. Breath-to-breath 
data were partitioned into a fast and slow ventilatory component. The influence of hyperoxia on 
the ventilatory response to CO2 showed that often a fast component is present. They say this fast 
component is of peripheral origin. The authors argue that the fast component is due to peripheral 
chemoreflex loop and the slow component to the central chemoreflex loop. During normoxia and 
hypoxia there is, besides a peripheral component, only one central component. So apart from 
peripheral O2–CO2 interaction, there is evidence for central O2–CO2 interaction.    
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(Juan, Calverley et al. 1984) 
Acute increase in PaCO2 in 4 men caused changes in contractility of diaphragm. Contractility 
was reduced when FETCO2 was >7.5% CO2. The diaphragm was influenced by acute respiratory 
acidosis when PaCO2 exceeded 54 mmHg. 
(Brackett Jr, Cohen et al. 1965) 
Exposed 7 resting men to 7% and then 10% CO2 on another day in a chamber for about 90 
minutes while taking serial arterial blood samples. FIO2 maintained at 0.21. Mean HCO3- 
increased from 24.4 to 25.9 mEq/L at 7% CO2 to 27.3 mEq/L at 10% CO2. Mean [H+]a increased 
from 38 nM/L (pH 7.42) to 49 nM/L (pH 7.31) to 68 nM/L (pH 7.17) over the same CO2 
increase. He concludes that there is only a modest generation of HCO3- from endogenous buffer 
stores during acute respiratory acidosis. There is a reliance on the renal system for effective 
buffering mechanisms to defend against extracellular [H+]. 
 
 
Figure A-38 
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Figure A-39 
 
Henderson–Hasselbalch equation for the bicarbonate buffer system is: 
pH = 6.1 + log10 [HCO3-, mEq/L]/(0.03 × PaCO2, mmHg), also 
pH = - log10 [H+] with concentration as nM/L or nEq/L, where 40 × 10-9 equivalents/L = pH of 
7.40. 
(Valtin 1983) 
Textbook on renal physiology with special treatment of H+ buffering and compensations for 
acute respiratory acidosis. Basics of buffering H+ derived from CO2 during exercise and 
hypercapnia to perserve alkaline pH near 7.40. Figures below from: Valtin H (2nd Ed.). Renal 
Function: Mechanisms preserving fluid and solute balance in health. Little, Brown and 
Company, Inc., Boston, MA, 1983, pp. 195-218. 
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Figure A-40 
Adapted from Figure 9-2. CO2 from tissue metabolism at rest or exercise diffuses into plasma 
and then RBCs where CA in RBCs produces H+ and HCO3-. HCO3- is exchanged for Cl- through 
a membrane pump. CO2 in RBC combines with Hb resulting in H+ that reduces Hb affinity for 
O2 at the tissue.  
 
 
Figure A-41 
Adapted from Figure 9-7. CO2 introduced from outside the body is a volitile acid added to the 
body as opposed to volitile acid produced by the body. CO2 produced by the body is removed 
primarily as HCO3-, as diagramed in Figure 9-2 above. The H+ produced from CO2 of 
hypercapnia cannot be buffered by the bicarbonate system. When H+ is buffered by HCO3- the 
carbonic acid formed quickly dissociates back to CO2 and H2O. Because CO2 and H2O are the 
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starting substrates, when CO2 is added to the body, the reaction H+ + HCO3-  H2CO3  CO2 + 
H2O is being driven to the left, and it cannot simultaneosly be driven to the right as would be 
required if the H+ were to be buffered by HCO3-. Instead, the H+ must be buffered by the 
nonbicarbonate buffers available to the body, in particular Hb. A large proportion of the added 
volitile acid is buffered by RBCs, which rapidly convert the added CO2 to HCO3- carried in the 
plasma.   
(Klocke 1987) 
Chapter 10 about CO2 transport in arterial and venous blood. Provides CO2 content in arterial 
and venous blood for a resting person as dissolved CO2, as HCO3-, and as carbamate. 
Approximate contribution of venous blood to CO2 transport is physical solution (6%), bound to 
proteins that include Hb (carbamino, 7%), and as HCO3- (87%).   
 
Figure A-42 
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Figure A-43 PCO2 (mmHg) 
(Bacal, Beck et al. 2008) 
Provides a recent (Table 22.7) that compiles assessment of exercise and mental performance as 
PCO2 increases. It appears that PCO2 <30 mmHg for durations relevant to EVA do not 
significantly impact physical and mental performance, at least well-learned tasks. 
 
 
Figure A-44 
 
 
 72 
 
(Wick 1966) 
Ten males in an unpressurized Gemini (G2C) suit were exposed to 0%, 1%, 2%, and 3% CO2 
with inlet flow at 11 cfm either during rest on a chair (mean 450 BTU/h) or while walking at 3 
mph (mean 2,050 BTU/h) on a level-grade treadmill. Subjects sat for 45 minutes to stabilize to 
the breathing gas condition, then over an unspecified interval various measurements with 
different gas sampling methods were done while still at rest or during treadmill exercise, 
estimated total interval from visor down <90 minutes. Arterial blood was drawn during this 
period. This appears to be the only instance where arterial blood from the radial artery to assess 
PaCO2 and pH was done in a suited subjects. Each subject did the 4 gas conditions at rest and 
during treadmill walk on separate days; 8 tests per subject. 
 
Figure A-45 Gemini full-pressure space suit. 
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Table A19.  Mean Respiration Data in Gemini Suit at 11 CFM at Rest and Walking at 3 
mph with 0% or 3% CO2 
inlet CO2 
(%) 
VT 
(L*) 
f 
(breathes/min) 
V̇E** 
(L*/min) 
metabolic rate 
(BTU/h) 
0 0.75 11.1 8.3 460 
3 0.92 15.5 14.2 490 
     
0 1.84 17.8 32.7 2,080 
3 2.46 20.8 51.7 2,020 
*unclear if volume is STPD or BTPS, suspect STPD. 
**V̇E from VT × f 
n = same 10 subjects for each row of results. 
 
 
. 
 
 
Figure A-46 
Figure 4-1. PaCO2 as a function of suit inlet 
CO2 (adapted) 
Figure A-47 
Figure 4-3. Peak pCO2 (PETCO2) at oral-
nasal sampler with noseclip as a function of 
suit inlet CO2 (adapted). 
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Figure A-48 
Figure 4-4. Mean inspired pCO2 (simultaneous 
double integration) as a function of suit inlet 
CO2 (adapted). 
Figure A-49 
Figure 4-7. Metabolic rate as a function of 
suit inlet CO2 (adapted). 
 
  
Figure A-50 
Figure 4-8. Arterial pH as a function of suit 
inlet CO2 (adapted). 
Figure A-51 
Figure 4-9. Respiration rate as a function of 
suit inlet CO2 (adapted). 
 75 
 
 
 
 
Figure A-52 
Figure 4-10. Tidal volume as a function of 
suit inlet CO2 (adapted). Note error on y-axis 
unit because VT is a volume and not a rate. 
Figure A-53 
Figure 4-11. Mean minimal values observed, 
PCO2 at the end of inspiration (adapted). Note 
x-axis is percent CO2. 
(Glatte Jr and Welch 1967) 
Early review of human CO2 exposure from 1967 extending to the 1920’s. Compiles his summary 
and conclusions from literature data into a convenient and novel tabulation (Table III) to assess 
acute and chronic responses in 6 major categories.  
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Figure A-54 
(Kronenberg and Drage 1973) 
Eight young men (22-30 years) and 8 healthy elderly men (64-73) were measured for ventilatory 
response to hypoxia and hypercapnia. Ventilatory response to hypoxia was measured as the 
exponential slope constant, k, of regression lines relating the logarithm of incremental ventilation 
to PAO2 during isocapnic progressive hypoxia. The ventilatory response to hypercapnia was 
measured as the slope of the regression lines relating ventilation to PACO2 during rebreathing 
with PAO2 >200 mmHg. Both the ventilatory and HR response were decreased in the elderly men 
compared to the young men. It decreased by 51% for the hypoxic ventilatory drive and 41% for 
the hypercapnic ventilatory drive. 
 
 
 
Figure A-55 Figure A-56 
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A-2 Hypercapnia in normobaric normoxia with rest and exercise in µG – Space Shuttle, ISS, 
Neurolab. 
(Laurie, Vizzeri et al. 2017) 
Seated, 6-degree head-down tilt (HDT), and then HDT plus 1% CO2 were compared in in the 
course of 1 hour. Several measurements related to vision were collected as well as PETCO2. 
Analysis of 1-carbon pathway genetics was performed from venous blood. The total experiment 
was 1 hour, so application of results to chronic µG or EVA are limited. There were no significant 
differences in hemodynamic variables or ocular variables between HDT and HDT plus 1% CO2 
(see Tables 1 and 2). PETCO2 increased from 37.7 to 40.4 mmHg from seated to HDT and then to 
42.1 mmHg for HDT plus 1% CO2. When subjects were classified by genotype group, the 
change in PETCO2 from seated to HDT plus 1% CO2 was greater in 4 subjects where both genes 
expressed alleles previously associated with vision changes in µG (MTRR 66 AG or CG and 
SHMT 1420 CG), designated SNP+ and 4 subjects where 1 gene or no genes had alleles 
associated with vision changes, designated SNP-. The change in PETCO2 from seated to HDT 
plus 1% CO2 was significantly greater in SNP+ than SNP- (see Figure 6a). Separation of subjects 
on the basis of their MTRR 66 genotype suggests that a protective factor against elevated 
PETCO2 (surrogate for PaCO2) is the AA genotype (see Figure 7). 
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Figure A-57 
 
 
Figure A-58 
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Figure A-59       Figure A-60 
 
(Kurazumi 2018) 
Fifteen men had 10-minute exposures to 10-degree HDT with and without 3% CO2. Data were 
collected before and after the HDT. Breathing gas was normoxic (21% O2, 3% CO2, and 76% 
N2). They tested 4 conditions: air breathing plus supine position, air breathing plus HDT, CO2 
breathing plus supine, and CO2 breathing plus HDT. ICP was computed with 2 methods (see 
their Methods). The addition of 3% CO2 had no significant effect on increasing ICP during the 
HDT. 
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Figure A-61 
(Marshall-Goebel 2018) 
Six men had 26 h exposures to 12-degree HDT with and without 0.5% CO2. The right internal 
jugular vein was indirectly measured in 4 places for cross-sectional area and contained blood 
volume (computed) after 26 hours. The addition of 0.5% CO2 made no contribution to the 
measured changes. 
 
 
Figure A-62 
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(Marshall-Goebel, Mulder et al. 2017) 
Nine men had 3.5 h exposures to 12-degree HDT with and without 1% CO2. ICP was measured 
with a transcranial Doppler-based noninvasive ICP meter. The addition of 1% CO2 had no 
further effect on ICP or intraocular pressure. 
 
 
Figure A-63 
 
 
Figure A-64 
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(Zwart, Gibson et al. 2012) 
Some astronauts are genetically predisposed to respond better in µG given the additional stress 
of adaptation to µG, which includes fluid shifts and mild hypercapnia. Metabolic predisposition 
can modify intracranial pressure, vascular reactivity, etc., leading to vision changes in some. See 
summary under #13. 
(James, Meyers et al. 2011) 
The authors confront the difficulty in defining unacceptable risk of acute hypercapnia. They 
could not prospectively define an adverse effect of hypercapnia. The incidence of headache on 
ISS associated with PCO2 near the time of headache was one response variable that could be 
evaluated. Their analysis concluded that the probability of headache is <1% if PCO2 is <2.3 
mmHg, but conclude that headache on ISS is not a serious medical concern.  
(Law, Van Baalen et al. 2014) 
Compilation of previous work from 2010 (Law, Watkins et al. 2010) and 2011 (James, Meyers et 
al. 2011) to systematically evaluate hypercapnia with a common symptom of headache in µG. 
But not all headache can be attributed to just hypercapnia. The fundamental question is whether 
there is a greater sensitivity or greater consequence of hypercapnia in µG. This is still an open 
question. Analysis of symptom records and associated chronic PCO2 levels on ISS provided 
enough data to perform logistic regression. Their analysis concluded that the probability of 
headache is <1% if PCO2 is <2.5 mmHg, 
 
 
Figure A-65 
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(Storm and Giannetta 1974) 
Two weeks of bed rest with PCO2 of 30 mmHg had no detrimental effect on complex tracking 
performance, eye-hand coordination, or problem solving ability. This was the first research to 
combine hypercapnia with bed rest. 4 groups of 6 subjects were tested under 4 conditions:  
Group 1 breathing air without bed rest, Group 2 breathing air with bed rest, Group 3 breathing 
CO2 without bed rest, and Group 4 breathing CO2 with bed rest. Hypercapnia or simulated µG 
either alone or combined had no significant effect on complex tracking performance, eye-hand 
coordination, or problem solving ability. A learning effect through time was present in all groups 
but there was no experimental treatment effect on the repetitive psychometric measures. 
 
 
Figure A-66  Note: Group 1 breathing air without bed rest, Group 2 breathing air with bed 
rest, Group 3 breathing CO2 without bed rest, and Group 4 breathing CO2 with 
bed rest. 
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(Hughson, Yee et al. 2016) 
Nine ISS astronauts had PETCO2 measured from a seated position (preflight) and in µG. Mean 
inspired CO2 increased from 0.6 mmHg for preflight to 3.2 mmHg inflight while PETCO2 
increased from 36.0 mmHg for preflight to 42.1 mmHg inflight. The author concludes that 
ventilation mechanics due to cephalad shift of organs may result in hypoventilation, or astronauts 
breathed ambient CO2 on ISS, or that the ventilatory response to CO2 is suppressed in the ISS 
µG environment. Because the inflight data was compared to seated preflight data, the author 
does concede that a part of the 6 mmHg difference in PETCO2 may be due to a seated posture 
versus a supine posture.  
 
 
Figure A-67 
(Law, Watkins et al. 2010) 
Operational Space Shuttle and ISS experience with management of PCO2, and descriptions of 
symptoms associated with particular PCO2 exposures. The report is a valuable compilation of 
exposure limits from several organizations and covers both spacecraft and space suit CO2 limits, 
as of 2010. 
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Figure A-68  Note: Data applies to normobaric resting subjects breathing air. Application of 
these results is to hypobaric resting and active astronauts breathing 100% O2.   
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Figure A-69  Note: These PCO2 limits established under normobaric (1 ATA) condition 
will have larger PICO2 than when the same PCO2 limits are applied under 
hypobaric (EVA) conditions. The difference in PICO2 for the same PCO2 at 
different ambient pressures (PB) is due to the presence of constant water vapor 
partial pressure (PH2O = 47 mmHg) at reduced total pressures; PICO2 = (PB–
47) × FICO2, FICO2 = PICO2/(PB–47) or FICO2 = PCO2/PB, and PCO2 = PB × 
[PICO2/(PB–47)]. 
(Cronyn, Watkins et al. 2012) 
Previous ISS limit for chronic PCO2 of 5.3 mmHg has been challenged based on reports of CO2-
linked symptoms (headaches and lethargy), but living in µG is multivariable. A hypothesis is that 
adaptation to µG may increase your sensitivity to low PCO2, but no evidence at present. It is 
equally likely that crew are exposed to high local CO2 concentrations that elicit symptoms, 
which is understandable. The main conclusions are to provide additional monitoring of PCO2 to 
understand better the CO2 exposure and to conduct dedicated research on hypercapnia in µG. 
There was no discussion about CO2 and EVA.  
(Michael and Marshall-Bowman 2015) 
Review of factors that increase intracranial pressure, including hypercapnia combined with µG 
adaptations, fluid shifts, changes in endothelium, acute exposure to high PCO2, and chronic 
exposure to 2–5 mmHg on ISS.  
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(Prisk, Elliott et al. 2000) 
Prisk measured the hypoxic and hypercapnic ventilatory responses before, during, and after 16 
days of spaceflight in 5 astronauts. In both µG and in pre-flight supine position the hypoxic 
ventilatory response was reduced compared to standing. During the hypercapnic ventilatory 
response test the ventilation at PCO2 of 60 mmHg was not significantly different in µG and in 
pre-flight supine position compared to standing. The authors suggest the increase in blood 
pressure in µG and in supine body position affected the carotid baroreceptors, which modified 
there response to hypoxia but not hypercapnia.   
 
 
Figure A-70 Figure A-71 
 
 
Figure A-72   
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A-3. Hypercapnia in normobaric hypoxia with rest and exercise in 1G. 
(Fan and Kayser 2013) 
See summary under #1. 
(Dahan, DeGoede et al. 1990) 
See summary under #1. 
 
(Nielsen and Smith 1952) 
Provided early evidence on the ventilatory response due to interactions between hypercapnia and 
hypoxia and hypercapnia and hyperoxia. V̇E dramatically increases, steep slope on V̇E versus 
PACO2 plot, in hypercapnic hypoxia and less so in hypercapnic hyperoxia. 
 
 
Figure A-73 
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(Ainslie and Poulin 2004) 
The acute hypoxic ventilatory response (AHVR) is enhanced by hypercapnia. Ainslie examines 
the acute effects of high, normal, and uncontrolled PETCO2 on ventilation, MCA blood flow, and 
MAP with hyperoxic and hypoxic male subjects. Hypoxia is one stimulus and is combined with 
hypercapnia. PETO2 was held at 8 steps between 300 and 45 mmHg and subjects were either 
hypercapnic (7.5 mmHg above subject normal), isocapnic (1.0 mmHg above subject normal), or 
poikilocapnic (PETCO2 freely changed). Slopes of ventilation, MCA, and MAP with SpO2 were 
greater in hypercapnia than the other 2 conditions. Hypoxia plus hypercapnia linked individual 
sensitivities of ventilation and CBF. Between-subject variability in the AHVR is linked to 
variability in CBF and MAP responses to hypoxia, which in-turn are sensitive to hypercapnic 
responses between subjects. 
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Figure A-74   
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(Wang, Yee et al. 2015) 
See summary under #4. 
 
A-4 Hypercapnia in normobaric hyperoxia with rest and exercise in 1G. 
(Bishop, Lee et al. 1999) 
Twelve males walked in a Launch and Entry Suit pressurized at 0, 0.5, 1.0, and 1.5 psid above 
ambient sea level pressure with visor closed and breathing 100% O2. PCO2 during inspiration 
was measured at the end of a resting 6 minute prebreathe followed by 2 minutes of standing and 
5 minutes of walking at 1.56 m/sec (3.5 mph). After a 10 minute seated recovery, the 5 minute 
walk was repeated with visor open so as to measure V̇O2. Suit CO2 rapidly increased to over 4% 
during walking and 8 of 12 were not able to complete the 5-minute walk. Aerobic fitness was a 
factor to complete the 5-minute walk (see summary under #13). 
 
Figure A-75 
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Figure A-76 
 
(Lambertsen, Hall et al. 1963) 
Early work on increased V̇E in response to hypercapnia in hypoxia and hyperoxia. See summary 
under #7. 
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Figure A-77 
(Henning, Sauter et al. 1990) 
See summary under #1. 
(Sheehy, Kamon et al. 1982) 
Breathing 4% (30 mmHg) or 5% (38 mmHg) CO2 in air or 50% O2 with 80% V̇O2max treadmill 
exercise for 10 minutes and 6 minutes of recovery showed no difference between baseline in 
reaction time, rotor pursuit, short-term memory, and reasoning ability. 
 
 
Figure A-78 
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Figure A-79  Note: Figure A-77 shows typical presentation of results for several 
psychomotor and mental performance tests. Note that neither 4% nor 5% CO2 
in air or 50% O2 had an effect on reasoning tests.   
(Vercruyssen 2014) 
4% CO2 in 50% O2 for 1 hour in resting subjects may slow information processing in the 
stimulus encoding stage or the response selection stage, or both. Results show increased 
information processing time by impairing the response selection stage of processing, plus other 
metrics of information processing.  
(Vercruyssen and Kamon 1984) 
Six tests about cognition and psychomotor performance did not change while breathing 2% CO2 
in 50% O2, or just 50% O2 in subjects working at 75% V̇O2max. The use of 50% O2 was justified 
to minimize cerebral hypoxia despite fluctuations in brain blood flow caused by changes in 
PCO2.  
 
 
Figure A-80 
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Figure A-81 Figure A-82 
(Vercruyssen, Kamon et al. 2007) 
Same methods as in 1984 publication but breathing gas was 3% CO2 in 50% O2 and 4% CO2 in 
50% O2. Again, there was no impairment in cognition or psychomotor performance: speed or 
accuracy of addition, multiplication accuracy, speed or accuracy of reasoning, and stabilometer 
balance. Headaches were reported by some subjects with rapid resolution on return to fresh air, 
with fewer cases on subsequent test days. Therefore habituation, desensitization, or 
acclimatization to CO2 was evident.  
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Figure A-83 
(Bloch-Salisbury, Lansing et al. 2000) 
Nine subjects (7 female) had a 2 hour exposure to mean hypocapnic (PETCO2 = 30 mmHg), 
normocapnic (PETCO2 = 38 mmHg), and hypercapnic (PETCO2 = 47 mmHg) breathing in 50% O2 
while at normobaric rest. Changes in EEG were observed, but no effects on several cognitive and 
vigilance tasks. This work is extremely relevant to at least resting EVA with small increase in 
PaCO2. 
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Figure A-84 
 
(Wang, Yee et al. 2015) 
Tested 20 subjects during acute, 5-minute hypercapnia from rebreathing. The procedure 
increased mean PCO2 in the breathing circuit from 36 mmHg in control air to about 47 mmHg 
under hypoxic (PO2 = 56 mmHg) or hyperoxic (PO2 = 150 mmHg) conditions. Also tested 
normocapnic hypoxic condition (PCO2 = 34 mmHg and PO2 = 47 mmHg in breathing circuit. In 
both hypercapnic cases there was an increase from 7 to 10 in the ratio of delta (δ) wave power to 
alpha (α) wave power (δ/α) from EEG during the rebreathing. There was no change in the ratio 
of δ/α between control (6.6) and normocapnic hypoxic condition (6.0). No cognitive or 
performance measures were taken over this short interval, just a demonstration that hypercapnia 
but not hypoxia caused EEG slowing, which might indicate a depression of cortical 
neuroelectrical activity. 
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Figure A-85 
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Figure A-86 
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Figure A-87 
 
(Dahan, DeGoede et al. 1990) 
See summary under #1. 
 
(Becker, Polo et al. 1996) 
Isocapnic hyperoxia stimulates ventilation in a dose-response manner. If isocapnia is not 
maintained, then hyperventilation is attenuated by a decrease in PaCO2. 
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Figure A-88 
(Ainslie and Poulin 2004) 
See summary under #3. 
A-5 Hypercapnia in hyperbaric normoxia with rest and exercise in 1G. 
A-6 Hypercapnia in hyperbaric hypoxia with rest and exercise in 1G. 
A-7 Hypercapnia in hyperbaric hyperoxia with rest and exercise in 1G. 
(Gill, Natoli et al. 2014) 
See summary under #1. 
(Lambertsen, Hall et al. 1963) 
See summary under #4. Lambertsen covers: O2 breathing without added CO2, CO2 added to O2 at 
increased pressure, and inhalation of CO2 with O2 at 1 ATA. 
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Figure A-89 
Figure A-89 shows no significant further increase in V̇E in response to the mild hyperoxia 
associated with EVA combined with hypercapnia. 
 
Figure A-90 
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Acute breathing of 3 ATM of PO2 without hypercapnia is associated with an increase in V̇E, 
arterial hypocapnia, and venous hypercapnia. Figure 3 shows the increase in V̇E with hyperoxia. 
The reason may be that vasoconstriction leads to an increase in PVCO2 that may reflect an 
increase in PCSFCO2. The increase in PCSFCO2 may then stimulate central chemoreceptors to 
increase V̇E even in the face of lowered PaCO2.  
 
Figure A-91 
Figure A-91 shows the depression of V̇E to hypercapnia in the presence of hyperoxia. However, 
while depression of V̇E occurred at a higher level of hypercapnia, stimulation of V̇E resulted when 
the same hyperoxia was administered with lower hypercapnia. So there is a complex interaction 
between PO2 and PCO2 in the chemical control of respiration. 
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Figure A-92 
Figure A-92 shows the change in V̇E for a change in PaCO2 and PVCO2 either while breathing 1 
ATA O2 or when PAO2 is held normal at 100 mmHg. A PO2 of 1 ATM produced a prominent 
depression in the slope of the respiratory response to hypercapnia. 
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(Michel, Sharma et al. 1969) 
PCO2 at the end of inhalation increased in suited subjects at 18.4 psia undergoing exercise at 
1000 and 2000 BTU/h. PCO2 at the end of inhalation is a measure of helmet washout under a 
range of helmet ventilation rates. A limit of 7.6 mmHg was exceeded in both the Gemini and 
Apollo suits with helmet ventilation at 6 actual cubic feet per minute when treadmill exercise 
exceeded 2000 BTU/h. 
 
 
Figure A-93  Note: Total ventilation in Gemini suit was partitioned between helmet and 
torso, 11.5 ACFM in Figure A-91 reflects about 6 ACFM in the helmet, see 
paper for other details. 
(Selkirk, Shykoff et al. 2010) 
Comprehensive evaluation of cognitive effects of 1.5% and 3% CO2 (sea level equivalent) on 
working divers breathing either O2 at 1.4 ATM or air at 0.3 ATM in 12 feet fresh water. Exercise 
was with cycle ergometer with three 30 minute exercises and 30 minutes of rests between during 
which cognition tests were performed while submerged. The test matric was extensive and not 
possible to succinctly summarize. Basic cognitive domains of simple reaction time, visual 
scanning, visuo-spatial processing, and learning were unaffected. The author notes “perplexing” 
results for other cognitive functions but says that long-term memory was decreased while divers 
were breathing CO2. Some subjects reported headache, shortness of breath, irritability, and lack 
of concentration.   
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(Haran and Lovelace 2015) 
Various combinations of 0%, 1%, and 2% CO2 (sea level equivalent) with high breathing 
resistance during dives at 12 feet fresh water with high exercise (85% V̇O2peak) for 60 minutes 
did not impair neurocognitive performance and postural stability. Although there were CO2-
related symptoms that precluded neurocognitive assessments in some subjects.  
 
 
Figure A-94 
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Figure A-95 
Note:  those few subjects who were removed from the study before the end of the 60 minute 
exercise period due to severe symptoms did not complete post-exercise neurocognitive 
assessments, so their data was not included in the pre-exercise neurocognitive assessments. This 
approach seems to bias results to those who were resistant to hypercapnia.    
(Fothergill, Hedges et al. 1991) 
Resting, 20 minute exposure to PETCO2 of 26 mmHg (hypocapnic), 47 mmHg (isocapnic), and 
57 mmHg (hypercapnic). Cognitive and psychomotor performance decreased at 6 ATA on air 
and more so at PETCO2 of 57 mmHg. But no N2–CO2 interaction that changed the threshold for 
CO2 narcosis. N2 narcosis lowered performance and disrupted accuracy, while hypercapnia plus 
N2 narcosis slowed performance rather than disrupting accuracy. Therefore high PETCO2 and 
PIN2 are additive in their effects on impairing cognitive and psychomotor performance. A 
limitation of this study was that they did not control for hyperoxia at 6 ATA.  
(Warkander, Norfleet et al. 1990) 
Exercise at 6.8 ATA with PETCO2 of about 62 mmHg increased to 72 mmHg when breathing 
resistance was rapidly increased and then to 90 mmHg during transition from the experiment, at 
which time he lost consciousness. Other subjects responded less dramatically but with equally 
high PETCO2. The authors conclude that severe hypercapnia does not necessarily correlate with 
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dyspnea and that severe disturbances in mental function can develop suddenly when high 
breathing resistance is encountered in diving. 
(Bitterman and Bitterman 1998) 
Authors explored that increased susceptibility to hyperoxia-induced seizures in the presence of 
hypercapnia is due to more than cerebral vasodilator effect of CO2. An increase in CO2 is also 
associated with changes in other vasoactive agents, such as nitric oxide (NO). Agents that 
suppress or enhance NO production were injected into rats and combined with 5% CO2 in 95% 
O2 or just 100% O2 with hyperbaric exposure to 5 ATA. Inhibition of NO production with or 
without hypercapnia postponed the appearance of hyperoxic seizures.  
A-8 Hypercapnia in hypobaric hyperoxia with rest and exercise in µG – EVA. 
A-9 Hypercapnia in hypobaric normoxia with rest and exercise in 1G. 
(Glatte Jr, Motsay et al. 1967) 
Seven men exposed to 3% CO2 at about 700 mmHg ambient pressure in a chamber for 5 days. 
Extensive blood and urine analysis showed little change: PaCO2 increased 3–4 mmHg with pH 
reduced from 7.40 to 7.32, urine HCO3- increased from 6.5 to 7.1 mEq/24 h, no remarkable 
difference to 100 watt exercise over 1 hour with V̇E increased about 2.5 L(BTPS)/min during rest, 
and no measurable changes in various psychomotor performance compared to baseline. 
Presentation of extensive results was somewhat confusing. 
A-10 Hypercapnia in hypobaric normoxia with rest and exercise in µG – Skylab. 
A-11 Hypercapnia in hypobaric hypoxia with rest and exercise in 1G. 
(Liu, Liu et al. 2015) 
Subjects breathed 25% O2 at 3,800 m altitude (12,500 ft with PIO2 ≈ 118 mmHg) plus 0.5, 3.0, 
and 5.0% CO2 (equivalent to 0.31, 1.89, and 3.14% CO2 at sea level) on separate days. Each day 
they exercised 3 times for 3 minutes with 30 minute rest between exercises. Authors concluded 
in hypobaric, mild hypoxic and hypercapnic environment that the cardiovascular system showed 
significant responses in heart rate, blood pressure, and cardiac autonomic regulation when 
breathing 5% CO2 (3.14% sea level equivalent) compared to other conditions. 
(Loeppky 1998) 
Exercise to V̇O2max on a cycle ergometer was done with male subjects breathing a PICO2 of 5.4, 
7.5, and 15.0 mmHg for 30 minutes. PB at the laboratory was 630 mmHg (5,400 ft altitude). 
Author attributes a lower RER with hypercapnic exercise to CO2 retention. The presence of CO2 
in inspired gas induces a relative ventilation insufficiency under conditions of strenuous exercise. 
A useful regression equation was provided that shows the change in V̇I as a function of PICO2 
and the ratio of V̇O2 to V̇O2max: 
Log10 V̇I = 1.174 + 0.00356 × PICO21.5 + (0.95 – 0.00636 × PICO2) × V̇O2/V̇O2max.  
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Figure A-96 
 
 
Figure A-97 
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Figure A-98 
(Krasnogor, Wempen et al. 1968) 
Six men exercised on bicycle ergometer at 100 watts 60 rpm for 3 hours while at 180 mmHg 
(3.48 psia, 35,000 ft altitude) in a chamber with PCO2 of 7.6 mmHg and FIO2 about 0.90. Same 
men did same protocol at 700 mmHg. Arterial blood gas, ventilation, and metabolic rate data 
indicated no significant impact of this acute mild hypercapnic and mild exercise at altitude and 
no significant difference when compared to same protocol at 700 mmHg. O2 consumption was 
about 1.2 L(STPD)/min for each protocol with no significant change in PaCO2 during the rest or 
exercise interval at 180 mmHg or at 700 mmHg, a PaCO2 of about 36 mmHg. Mean arterial pH 
was never lower than 7.39. This was convincing evidence in 1968 that modest continuous work 
combined with modest hypercapnia could be performed under space suit conditions. 
 
Figure A-99 
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Figure A-100 
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Figure A-101 
(Luft, Finkelstein et al. 1974) 
Experiments conducted in Albuquerque with PB of about 632 mmHg (5,000 ft altitude). Twelve 
young men (26.5 years) breathed air and air with PICO2 of 15 mmHg during stepped bicycle 
ergometry to the point where they could not maintain a metronome pedaling rhythm that 
produced 50 rpm. The stepped protocol required about 15 minutes, then 30 minutes of recovery 
while still breathing the test gas. The main conclusion was that the combination of metabolic 
acidosis from anaerobic metabolism in leg muscles combined with incomplete compensated 
respiratory acidosis from hypercapnia taxed the respiratory response such that CO2 retention was 
evident. Hypercapnia resulted in a decrease in RER (Figure A-105), an indication of CO2 
retention. Blood gases were collected on 10 of the 12 men, showing a decrease in PaCO2 during 
exercise on air while an increase during exercise with hypercapnia (Figure A-106), with a critical 
rise in [H+]a (Figure A-107). There were no differences seen in serum electrolyte concentration, 
even after corrected for the transient decrease in plasma volume due to exercise (Figure A-108 
and Figure A-109). 
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Table A22.  Select Means for Exercise EVA with PICO2 of 15 mmHg (Luft 1974) 
exer 
kpm/ 
min 
 
exer 
watts 
exer 
kcal/ 
min 
V̇I 
L(BTPS)/ 
min 
 
HR 
bpm 
V̇O2 
L(STPD)/ 
min 
 
∆ O2  
(e – c) 
V̇CO2 
L(STPD)/ 
min 
 
∆ CO2 
(e – c) 
 
 
RER 
300 
cont 
exper 
50 5  
27.67 
41.04 
 
111 
114 
 
0.89 
0.93 
 
0.04 
 
0.84 
0.66 
 
-0.180 
 
0.94 
0.71 
          
600 
cont 
exper 
100 8  
40.00 
58.70 
 
128 
131 
 
1.31 
1.33 
 
0.02 
 
1.22 
1.094 
 
-0.126 
 
0.93 
0.82 
          
900 
cont 
exper 
150 11  
62.66 
89.45 
 
152 
155 
 
1.95 
1.97 
 
0.02 
 
1.94 
1.84 
 
-0.100 
 
0.99 
0.94 
Note: No difference between experiment and control for O2 consumption as exercise increases 
but a decrease in CO2 production difference, as reflected in lower RER for hypercapnia with 
exercise. 
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Figure A-102 Figure A-103 
 
 
Figure A-104 Figure A-105 
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Figure A-106 Figure A-107 
  
Figure A-108 Figure A-109 
A-12. Hypercapnia in hypobaric hyperoxia with rest and exercise in 1G. 
A-13. Human response variation to hypercapnia/genetics, gender, etc.  
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(Bishop, Lee et al. 1999) 
Aerobic fitness (V̇O2max) of males during hypercapnic exercise correlated with completed walk 
time in the LAE suit at 16.2 psia (1.5 psid during test at sea level pressure). Finishers had a mean V̇O2peak of 56.1 mL/kg/min versus non-finishers of 42.1 mL/kg/min. Fit subjects introduced less 
CO2 into the helmet space since inspired CO2 were lower in those that finished after 3 minutes of 
walking than non-finishers at both 1.0 and 1.5 psid above ambient sea level pressure. Fit people 
can extract more O2 (more efficient) to support muscle metabolism through various anatomical 
and biochemical adaptations, plus differences in genetic endowment. See summary under #4. 
 
Figure A-110 
(Morelli, Badr et al. 2004) 
Men and women have different sensitivity (peripheral chemoreflex sensitivity) in ventilation 
response to hypercapnia, which is modified after exposure to hypoxia. Ventilatory response to 
CO2 above a set point was increased in men compared to women before exposure to episodic 
hypoxia, independent of the PO2 maintained during the rebreathing trial. Enhancement of the 
acute ventilatory response to CO2 after episodic hypoxia is sex dependent. 
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Table A23.  Response Before Episodic Hypoxia Breathing 
rebreather PO2 condition during 
hypercapnic ventilatory response 
(HVR) 
mean male HVR 
(L/min/mmHg CO2) 
mean female HVR 
(L/min/mmHg CO2) 
hypoxic PO2 of 50 mmHg 5.19 4.70 
hyperoxic PO2 of 150 mmHg 4.37 3.21 
Table A24.  Response After Episodic Hypoxia Breathing 
rebreather PO2 condition during 
hypercapnic ventilatory response 
(HVR) 
mean male HVR 
(L/min/mmHg CO2) 
mean female HVR 
(L/min/mmHg CO2) 
hypoxic PO2 of 50 mmHg 9.52 5.97 
hyperoxic PO2 of 150 mmHg 5.73 3.83 
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Figure A-111 
(Laurie, Vizzeri et al. 2017) 
See summary under #2. 
(Lambertsen 1960) V̇E response to 2%, 4%, and 6% CO2 in normobaric air is not universally the same for all male 
subjects. There are those that respond with a vigorous increase in V̇E in response to an increase in 
PACO2 (∆V̇E/∆PACO2 ratio) and those that do not.  
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Figure A-112 
  
Figure A-113 Figure A-114 
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Note: Significance of Figure 4 is that there exists a linear relationship between PaCO2 and PvCO2 
and pH. The relationship between change in PCO2 and pH has a slope of -0.007 pH units/1.0 
mmHg increase in PCO2. For example, a 10 mmHg increase in PaCO2 from 40 to 50 mmHg will 
reduce normal pH of 7.400 to 7.325.  
(Sebert, Barthelemy et al. 1990) 
Seven men and 7 women were compared after a single-breath 13% CO2 hypercapnia in normoxic 
and hyperoxic normobaric exposures. Mean sensitivity (∆V̇E/∆PETCO2) in normoxia was greater 
in men (0.37 L(BTPS)/min/mmHg PETCO2) than women (0.15). Sensitivity decreased in hyperoxia 
for both men and women but was still greater in men (0.19) than women (0.11). A general 
consensus is that women are less sensitive to chemical stimulation from hypercapnia, hypoxia, 
and hypercapnic hypoxia, which may be explained by different hormonal status.  
 
 Figure A-115 
(Law, Young et al. 2017) 
CO2 training provided by rebreathing for about 10 minutes from an anesthesia bag. The number 
of symptoms from 130 astronauts reported per session out of the possible 24 was related to age 
and sex, with those older slightly more likely to report symptoms. Women reported more 
symptoms on average than men (men: 3.7, women: 4.7). Respiratory symptoms (90%), flushing 
sensation / sweating (56%), and dizziness/feeling faint/lightheadedness (43%) were the top 
symptoms. Only headache reached statistical significance in differences between men (13%) and 
women (37%) after adjustment for multiple testing. Among those with multiple training sessions, 
respiratory symptoms were the most consistently reported. 
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Figure A-116 
(Bloch-Salisbury, Lansing et al. 2000) 
See summary under #4. 
 
Figure A-117 
(Dahan, DeGoede et al. 1990) 
See summary under #1. The results of their breath-to-breath analysis of the hyperoxic 
experiments indicate that there is a great diversity between subjects with regard to the magnitude 
of the peripheral component of ventilatory response to CO2. 
(Haywood and Bloete 1969) 
Twenty women breathed 5 to 10 minutes (reaching steady-state ventilation) normobaric air with 
0%, 4%, 5%, 6%, and 7.5% CO2. Results of ∆V̇E/∆PACO2 were compared to previous studies 
with men. Women’s ∆V̇E/∆PACO2 were higher than men as well as respiration rate while 
breathing 4 or 5% CO2. 
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Figure A-118  
(Ainslie and Poulin 2004) 
See summary under #3. 
(Gill, Natoli et al. 2014) 
See summary under #1. 
(Zwart, Gibson et al. 2012) 
Metabolic variables do not change in µG in response to mild chronic hypercapnia, just that 
Cystathionine, for example, is higher in those with ocular changes (OC+) than in those without 
ocular changes (OC-). The hypothesis is that modification in vascular reactivity due to chronic 
CO2 combined with fluid changes and other changes associated with µG manifest in ocular 
changes in a subset of astronauts with genetic alterations in specific metabolic pathways.       
 
Figure A-119 
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Figure A-120 
Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
(Clark, Sinclair 
et al. 1980) 
normo normo PCO2 
10 
20 
30 
40 
yes yes 1 yes  1 
(Menn, Sinclair 
et al. 1970) 
normo normo PICO2 
8 
15 
21 
30 
yes yes 1 yes  1 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
(Graham, 
Wilson et al. 
1982) 
normo normo PCO2 
15.2 
30.4 
45.6 
yes yes 1 yes  1 
(Jacobi, Iyawe 
et al. 1987) 
normo normo hyper 
see 
paper 
yes yes 1 yes  1 
(Ellingsen, 
Sydnes et al. 
1987) 
normo normo PCO2 
7.6 
15.2 
yes  1 yes  1 
(Sayers, Smith 
et al. 1987) 
normo normo PCO2 
34.2 
41.8 
49.7 
57.0 
yes  1 yes yes 1 
(Bishop, Lee et 
al. 1999) 
normo hyper hyper 
see 
paper 
yes yes 1 yes  4 
(Vercruyssen 
2014) 
normo hyper PCO2 
30.4 
yes  1  yes 4 
(Vercruyssen, 
Kamon et al. 
2007) 
normo hyper PCO2 
22.8 
30.4 
yes yes 1  yes 4 
(Vercruyssen 
and Kamon 
1984) 
norm hyper PCO2 
15.2 
yes yes 1  yes 4 
(Liu, Liu et al. 
2015) 
hypo hypox PCO2 
2.3 
14.3 
yes yes 1 yes  11 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
23.8 
(Loeppky 1998) hypo hypox PICO2 
5.4 
5.7 
7.5 
9.4 
15.0 
yes yes 1 yes  11 
(Forster, Klein 
et al. 1982) 
norm norm PICO2 
7 
14 
21 
28 
35 
42 
yes  1 yes  1 
(Sheehy, 
Kamon et al. 
1982) 
norm hyper PCO2 
30.4 
38.0 
yes yes 1  yes 4 
(Henning, 
Sauter et al. 
1990) 
norm norm PCO2 
45.6 
yes  1  yes 1 
(Henning, 
Sauter et al. 
1990) 
norm hyper PCO2 
45.6 
yes  1  yes 4 
(Gill, Natoli et 
al. 2014) 
norm norm PCO2 
49 
57 
65 
yes yes 1 yes yes 1 
(Gill, Natoli et 
al. 2014) 
hyper hyper PCO2 
41 
yes yes 1 yes yes 7 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
49 
57 
65 
(Fan and 
Kayser 2013) 
norm hypox hyper 
see 
paper 
yes yes 1 yes  3 
(Fan and 
Kayser 2013) 
norm norm hyper 
see 
paper 
yes yes 1 yes  1 
(Poon and 
Greene 1985) 
norm norm hyper 
see 
paper 
yes yes 1 yes  1 
(Laurie, Vizzeri 
et al. 2017) 
norm norm PCO2 
7.6 
yes  0 yes  2 
(Kurazumi 
2018) 
norm norm PCO2 
22.8 
yes  0 yes  2 
(Marshall-
Goebel 2018) 
norm norm PCO2 
3.8 
yes  0 yes  2 
(Marshall-
Goebel, Mulder 
et al. 2017) 
norm norm PCO2 
7.6 
yes  0 yes  2 
(Michel, 
Sharma et al. 
1969) 
hyper hyper hyper 
see 
paper 
yes yes 1 methods methods 7 
(Law, Van 
Baalen et al. 
2014) 
norm norm hyper 
see 
paper 
yes  0  yes 2 
(Law, Watkins 
et al. 2010) 
norm norm hyper 
see 
paper 
yes  0  yes 2 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
(James, Meyers 
et al. 2011) 
norm norm hyper 
see 
paper 
yes  0  yes 2 
(Cronyn, 
Watkins et al. 
2012) 
norm norm hyper 
see 
paper 
yes  0  yes 2 
(Lambertsen 
1960) 
norm norm PCO2 
<45.6 
yes  1 yes  1 
(Lambertsen, 
Hall et al. 1963) 
norm hyper PCO2 
11.4 
22.8 
yes  1 yes  4 
(Lambertsen, 
Hall et al. 1963) 
hyper hyper PCO2 
11.4 
22.8 
yes  1 yes  7 
(Storm and 
Giannetta 1974) 
norm norm PCO2 
30 
yes  0  yes 2 
(Storm and 
Giannetta 1974) 
norm norm PCO2 
30 
yes  1  yes 1 
(Satish, 
Mendell et al. 
2012) 
norm norm PCO2 
0.45 
0.76 
1.90 
yes  1  yes 1 
(Allen, 
MacNaughton 
et al. 2016) 
norm norm PCO2 
<1.06 
yes  1  yes 1 
(Allen, 
MacNaughton 
et al. 2018) 
norm norm PCO2 
0.5 
1.1 
yes  1  yes 1 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
1.9 
(Rodeheffer, 
Chabal et al. 
2018) 
norm norm PCO2 
0.45 
1.9 
11.4 
yes  1  yes 1 
(Bakó-Biró, 
Clements-
Croome et al. 
2012) 
norm norm PCO2 
<3.8 
yes  1  yes 1 
(Hughson, Yee 
et al. 2016) 
norm norm PCO2 
3.8 
yes  0 yes  2 
(Michael and 
Marshall-
Bowman 2015) 
norm norm hyper 
see 
paper 
yes  0  yes 2 
(Bloch-
Salisbury, 
Lansing et al. 
2000) 
norm hyper hyper 
see 
paper 
yes  1 yes 
EEG 
yes 4 
(Wang, Yee et 
al. 2015) 
norm hyper hyper 
see 
paper 
yes  1 yes 
EEG 
 4 
(Wang, Yee et 
al. 2015) 
norm hypo hyper 
see 
paper 
yes  1 yes 
EEG 
 3 
(Wang, Yee et 
al. 2015) 
norm hypo normo 
see 
paper 
yes  1 yes 
EEG 
 norcapnic 
hypoxia 
(Selkirk, 
Shykoff et al. 
2010) 
hyper hyper PCO2 
11.4 
22.8 
yes yes 1 yes yes 7 
(Weybrew 
1970) 
norm norm PCO2 
22.8 
yes  1  yes 1 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
(Haran and 
Lovelace 2015) 
hyper hyper PCO2 
7.6 
15.2 
yes yes 1 yes yes 7 
(Glatte Jr, 
Motsay et al. 
1967) 
hypo norm PCO2 
21 
yes yes 1 yes yes 9 
(Reynolds, 
Milhorn et al. 
1972) 
norm norm PCO2 
22.8 
38.0 
45.6 
53.2 
yes  1 yes  1 
(Balanos, 
Talbot et al. 
2003) 
norm norm hyper 
see 
paper 
yes  1 yes  1 
(Warkander, 
Norfleet et al. 
1990) 
hyper hyper hyper 
see 
paper 
yes yes 1 yes yes 7 
(Fothergill, 
Hedges et al. 
1991) 
norm norm PICO2 
2 
38 
49 
yes ? 1 ? yes 1 
(Fothergill, 
Hedges et al. 
1991) 
hyper hyper PICO2 
3 
20 
29 
yes ? 1 ? yes 7 
(Nielsen and 
Smith 1952) 
norm hypo PCO2 
<38.0 
yes  1 yes  3 
(Bitterman and 
Bitterman 1998) 
hyper hyper hyper 
see 
paper 
yes  1 yes 
(animal) 
 7 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
(Prisk, Elliott et 
al. 2000) 
norm hypo hyper 
see 
paper 
yes  0 yes  2 
(Prisk, Elliott et 
al. 2000) 
norm hyper hyper 
see 
paper 
yes  0 yes  2 
(Ainslie and 
Poulin 2004) 
norm hyper hyper 
see 
paper 
yes  1 yes  4 
(Ainslie and 
Poulin 2004) 
norm hypo hyper 
see 
paper 
yes  1 yes  3 
(Ainslie and 
Duffin 2009) 
norm norm hyper 
see 
paper 
yes yes 1 yes  1 
(Frey, Sulzman 
et al. 1998) 
norm norm PCO2 
5.3 
9.1 
yes yes 1 yes yes 1 
(Manzey and 
Lorenz 1998) 
norm norm PCO2 
5.3 
9.1 
yes  1  yes 1 
(Sliwka, 
Krasney et al. 
1998) 
norm norm PCO2 
5.3 
9.1 
yes  1 yes  1 
(Zwart, Gibson 
et al. 2012) 
norm norm PCO2 
3 
mmHg 
yes yes 0 yes  2 
(Juan, Calverley 
et al. 1984) 
norm norm hyper 
see 
paper 
yes  1 yes  1 
(Brackett Jr, 
Cohen et al. 
1965) 
norm norm PCO2 
53 
76 
yes  1 yes  1 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
(Valtin 1983) norm norm hyper 
see 
chapter 
yes  1 yes   
(Bacal, Beck et 
al. 2008) 
norm norm hyper 
see 
chapter 
yes  1 yes yes 1 
(Wick 1966) norm norm PCO2 
7.6 
15.2 
22.8 
yes yes 1 yes  1 
(Wong 1992)   hyper 
see 
paper 
yes yes 1 yes yes  
(Glatte Jr and 
Welch 1967) 
norm norm PCO2 
4 to 21 
yes yes 1 yes yes 1 
(Sinclair, Clark 
et al. 1971) 
norm norm PCO2 
21 
yes yes 1 yes  1 
(Krasnogor, 
Wempen et al. 
1968) 
hypo hypo PCO2  
7.6 
yes yes 1 yes  11 
(Alexander, 
West et al. 
1955) 
norm norm PCO2  
22.3 
38.0 
yes  1 yes  1 
(Kronenberg 
and Drage 
1973) 
norm norm hyper 
see 
paper 
yes  1 yes  1 
(Luft, 
Finkelstein et 
al. 1974) 
hypo hypo PICO2 
15 
yes yes 1 yes  11 
(Weitzman, 
Kinney et al. 
1969) 
norm norm PCO2  
0 to 
22.8 
yes  1  yes 
(vision) 
1 
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Table A25.  Literature Specific to Acute Space Suit Hypercapnia Limits 
reference PB O2 CO2 rest exer grav phys neuro code 
(Sun, Sun et al. 
1996) 
norm norm PCO2  
19 
yes  1  yes 
(vision) 
1 
(Yang, Sun et 
al. 1997) 
norm norm PCO2  
19 
yes  1  yes 
(vision) 
1 
Note 1: In most cases PCO2 is estimated from FICO2 provided by the author with the assumption 
that research was done at sea level pressure. Therefore, the actual as-tested PCO2 may be slightly 
lower than tabulated if research was done at <760 mmHg. 
Note 2: “see paper” designation often means that CO2 was added to breathing gas to achieve a 
specific hypercapnic PETCO2, PACO2, or even blood-gas PaCO2, so no specific PCO2 is reported 
by the author. 
 
(Wong 1992) 
Extensive review in 1992 about CO2 exposure to set SMAC limits for long-duration space 
habitation. Provided a Toxicity Summary Table applicable to consideration of limits for EVA, so 
is reproduced here along with cited references, as additional resource. 
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Figure A-121.1 
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Figure A-121.2 
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Figure A-121.3 
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Figure A-121.4 
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Figure A-121.5 
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Figure A-121.6 
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Figure A-121.7 
 140 
 
 
Figure A-121.8 
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Figure A-121.9 
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Figure A-121.10 
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Figure A-122 
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